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              Mitochondria play essential roles in cellular energy production via mitochondrial 
respiratory chain (RC), which contains five complexes. NADH:ubiquinone 
oxidoreductase (complex I) is the largest complex that catalyzes the first step of electron 
transport of RC. Due to the central role of RC in cellular metabolism, any dysfunction of 
RC will cause severe disease with multi-system disorders. Among all of mitochondrial 
RC disorders, mitochondrial complex I deficiency is the most common case. Moreover,   
mitochondrial complex I is also the major source of reactive oxygen species (ROS) in 
cells, which now is believed to play very important roles in aging and aging-related 
diseases such as neurodegenerative diseases, diabetes and cancer. Therefore, the research 
on mitochondrial complex I has now become an exciting and fast developing field.  
GRIM-19, which was initially identified as a nuclear protein, has important roles in 
interferon-β (IFN) and retinoic acid (RA) induced apoptosis and was also reported to co-
purify with mitochondrial complex I. However, the relationship between GRIM-19 and 
complex I was not clear.  This study clearly demonstrates that GRIM-19 is a subunit of 
mitochondrial complex I by showing: (1) GRIM-19 interacted with various mitochondrial 
complex I subunits and was physically present in mitochondrial complex I. (2) In GRIM-
19 knockout mice, mitochondrial complex I holoenzyme could not be fully assembled 
and complex I activity was totally abolished, indicating that GRIM-19 is essential for 
complex I assembly and enzymatic activity. In addition, several important functional 
domains in GRIM-19 were identified. The mitochondrial localization sequences were 
defined at the N-terminus, the electron transfer activity domain was found in the middle 
and the last 10 amino acid at C-terminus enhanced the assembly ability of GRIM-19 to 
 xvi
complex I. Based on the domain-mapping information, a dominant-negative GRIM-19, 
which can specifically decrease mitochondrial membrane potential, was generated.  
 In summary, I have demonstrated that GRIM-19 was a crucial subunit in 





































































1.1 Mitochondrion and mitochondrial respiratory chain 
       The cell is the basic structural and functional unit of all living organisms 
(Bruce, 2002). All of the cell’s behavior, such as movement, secretion, division 
and activation of signaling pathway, required the supply of energy. A small 
organelle inside the cells called mitochondrion fulfills this important role. 
1.1.1 Mitochondrion 
                              
                                                         http://cellbio.utmb.edu/cellbio/mitoch1.htm 
             Figure 1.1.  An electron microscopy picture  of a  mitochondrion      
       Mitochondria in animal cells were first identified as a subcellular structure by 
light microscopy in the 1840s (Immo, 2002).  Plant mitochondria were observed 
in 1904. Mitochondria can be distinguished from other cellular organelles by their 
ability to be stained with the redox dye Janus Green (Helen, 1938).  This dye can 
be oxidized into a colored form by cytochrome c oxidase in mitochondria.  
          Mitochondria can be found in most eukaryotic cells (Henze et al., 2003). 
They serve as the power supply center in cells by generating the majority of ATP 
for all kinds of cellular activities. The shapes of mitochondria are usually rod-like 
or thread-like. The number of mitochondrion depends on the cell type ranging 
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from 1 to thousands of mitochondria per cell (Alberts et al., 1994 and Voet et 
al.,.2006) The diameters of mitochondria is like a bacterium from 1 to 10 
micrometers (μm).  Although the nucleus contains most of the DNA in cells, the 
mitochondrion has its own genome (Wolstenholme, 1992). 
 
1.1.2 Mitochondrion structure 
 
           
                                       http://en.wikipedia.org/wiki/Mitochondria 
         Figure 1.2. The structure of a mitochondrion      
         Like the nucleus, the mitochondrion contains double membranes. The outer 
membrane of the mitochondrion is quite smooth. However the inner membrane is 
convoluted into cristae.  These two membranes and cristae separate a 
mitochondrion into five distinct compartments: outer membrane, inter-membrane 
space, inner membrane, cristae space and mitochondrial matrix.  
(1) Mitochondrial outer membrane 
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         The mitochondrial outer membrane encloses the whole organelle. The 
protein - phospholipid ratio of the mitochondrial outer membrane is about 1:1 
by mass, similar to the cell plasma membrane. It contains only about 5% of 
the total mitochondrial proteins. The major protein is porin which makes the 
mitochondrial outer membrane permeable to molecules of about 10 kDa or 
less (the size of the smallest proteins). Ions, nutrient molecules, ATP, ADP, 
etc. can also pass through the outer membrane. Several enzymes are located in 
the outer membrane such as monoamine oxidase and NADH/cytochrome b5 
oxido-reductase.  
                 (2) Mitochondrial intermembrane space 
         The mitochondrial intermembrane space is the space between the outer 
membrane and the inner membrane. It contains about 5% of mitochondrial 
proteins. Some portion of cytochrome c (Cyt c), an extrinsic protein of the 
respiratory electron transport chain involved in transferring electrons from 
Complex III to Complex IV, is located here. Most of the dehydrogenases of 
the inner mitochondrial membrane have access to the matrix side only. 
However, some, such as glycerol 3-phosphate dehydrogenase, which 
generates reducing equivalents from cytosolic NADH and donates them to the 
electron transport chain, have access to the intermembrane space. 
      (3) Mitochondrial inner membrane. 
         The structure of the mitochondrial inner membrane is highly complex 
and rich of proteins (the ratio of proteins to lipids is about 3:1 by weight). It 
contains about 20% of the total mitochondrial proteins. The mitochondrial 
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inner membrane also contains an special lipid, cardiolipin (also called 
bisphosphatidylglycerol), which accounts for about 20% of the total lipid 
content of the inner membrane (McMillin et al., 2002). The inner membrane 
is freely permeable only to oxygen, carbon dioxide, and water. There are three 
major types of enzyme complexes in the mitochondrial inner membrane 
including all of the complexes of the electron transport system, the ATP 
synthetase complex, and transport proteins (Alberts et al., 1994). 
                 (4) Mitochondrial cristae space    
Mitochondrial cristae are the internal compartments which are formed by 
the convoluted inner membrane. Many types of cytochromes are localized in 
the mitochondrial critstae space. 
                  (5) Matrix 
The majority of mitochondrial proteins are located in the mitochondrial 
matrix. The matrix contains the enzymes responsible for the citric acid cycle 
reactions and fatty acid oxidation (Alberts et al., 1994).  In addition, the 
matrix also contains the ribosomes and other enzyme systems responsible for 
the synthesis of mitochondrial DNA (mtDNA), RNA and proteins. Because of 
the folds of the cristae, no part of the matrix is far from the inner membrane. 
Dissolved oxygen, water, carbon dioxide and the recyclable intermediates can 
diffuse into the matrix rapidly. 
    
1.1.3 Mitochondrial oxidative phosphorylation 
 5
           Why is the mitochondrion the “powerhouse” of the cell? This is because of 
the special capability of mitochondria to carry out oxidative phosphorylation. So 
far most of usable energy derived from fuel molecules such as carbonhydrate or 
fats comes from mitochondrial oxidative phosphorylation.  
          Oxidative phosphorylation is an efficient metabolic pathway that utilizes 
the energy released from the oxidation of fuel molecules to generate adenosine 
triphosphate (ATP), the major energy supplier in cells. During this process, 
electrons are transferred from electron donors such as NADH and FADH2 to the 
electron acceptors such as oxygen via redox reactions. The energy released from 
these redox reactions is efficiently used to generate ATP. Compared to glycolysis, 
oxidative phosphorylation is a much more efficient way to utilize the energy from 
fuel molecules. For example, one molecule of glucose can only generate 4 
molecules of ATP in glycolysis pathway, however, one molecule of glucose can 
produce about 32 molecules of ATP via the oxidative phosphorylation pathway 
(Rich 2003).
          In prokaryotes, redox reactions of oxidative phosphorylation are carried out 
by a series of protein complexes located in the cells’ inner membranes, whereas in 
eukaryotes these protein complexes, which are called electron transport chain 
(ETC) or respiratory chain (RC) , are located in the mitochondrial inner 
membrane. 
1.1.4 Mitochondrial respiratory chain (RC) and membrane 
potential (∆ψm). 
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             The mitochondrial respiratory chain consists of five multi-subunit 
complexes (Complexes I-V) and two additional mobile electron carriers: 
coenzyme Q10 and cytochrome c. Complex I, III and IV pump protons across the 
mitochondrial inner membrane from the matrix to the intermembrane space to 
generate a proton gradient, also called mitochondrial membrane potential (∆ψm). 
The electrochemical energy of this membrane potential is then used to drive ATP 
synthesis by Complex V. An overview of the morphology and function of RC is 
illustrated in Figure 1.3 
 
                                            Adopted from mitochondrial respiratory chain lecture by Antony Crofts 
            Figure 1.3.  A schematic picture of the morphology and function of the RC. 
 
             (1) NADH: ubiquinone oxidoreductase (Complex I) 
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               The mitochondrial Complex I, which carries out the first step of the 
electron transport reactions in RC, is also referred to NADH: ubiquinone 
dehydrogenase or NADH: ubiquinone oxidoreductase (Vanlerberghe et al.,1997). 
The total reaction catalyzed by Complex I can be described as: 
NADH + Q + 5H +i<==> NAD+ + QH2 + 4H+o 
 
Q and QH2 refer to the oxidized and reduced form of ubiquinone, respectively. “i” 
stands for inside (matrix side),. “o” stands for outside (intermembrane space ), 
and H+ refers to proton.  
           The NADH: ubiquinone oxidoreductase (Complex I) of the RC catalyzes 
the oxidation of NADH, the reduction of ubiquinone, and the transfer of 4 protons 
across the mitochondrial inner membrane. Electron transfer starts from the 
peripheral domain of Complex I where NADH is oxidized and 2 electrons are 
transferred to flavin mononucleotide (FMN). The electrons are then passed to the 
iron-sulfur centers which are also located in the hydrophilic peripheral domain 
(Sazanov et al., 2006). Through the iron-sulfur centers, the electrons are finally 
transferred to ubiquinone (also called coenzyme Q, CoQ or Q) which is close to 
the interface between the peripheral and intra-membrane domains (Hirst 2005). 
Simultaneously, ubiquinone (Q) takes up two protons from the matrix side, to 
form fully reduced ubiquinol (QH2). The hydrophobic ubiquinol feeds into a 
ubiquinone pool inside the inner membrane and diffuses to complex III. Complex 
I produce one QH2 per NADH oxidized. During the process of electron transfer 
from NADH to ubiquinone, Complex I pumps 4 protons across the coupling 
membrane to generate an inner membrane proton potential.  
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          (2) Succinate:ubiquinone oxidoreductase ( Complex II)  
                      The overall reaction catalyzed by Complex II can be described as: 
succinate + Q <==> fumarate + QH2
             Complex II is the simplest complex in RC, containing only 4 nuclear- 
encoded subunits (Cecchini, 2003). The two largest subunits form the peripheral 
arm of Complex II which acts as the succinate dehydrogenase in the citric acid 
cycle. The remaining two subunits (anchor proteins) are integrated into the 
mitochondrial inner membrane (Horsefield et al., 2004).  The peripheral arm 
associates with anchor proteins to form a functional Complex II. Electrons from 
the oxidation of succinate to fumarate are channeled through this complex to 
ubiquinone. Therefore, Complex II is an important enzymatic complex linking 
both the citric acid cycle and the mitochondrial respiratory chain. In the critic acid 
cycle, complex II oxidizes succinate to fumarate. The electrons from succinate are 
accepted by FAD which is subsequently reducd to FADH2, during the oxidation 
of succinate to fumarate. FADH2 is then reoxidized by electron transfer through a 
series of three ion-sulfur centers of Complex II to ubiquinone, yielding QH2. 
Complex II only generates one QH2 per succinate oxidized and does not pump any 
proton across the inner membrane.  
           Complex I and Complex II are the major source of superoxide radicals in 
cells. Both of them transfer electrons to ubiquinone which then pass the electrons 
to Complex III. Ubiquinone is the only non-protein electron carrier of the 
mitochondrial respiratory chain. Its highly hydrophobic property makes ubiquione 
dissolved only within the membrane. The quinine ring of ubiquinone accepts 2 
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electrons and is reduced to ubiquinol (QH2). Ubiquinone can also accept a single 
electron to generate ubisemiquinone radicals (QH-). QH- can be very harmful due 
to its ability to generate superoxide radicals (O2-). O2- has limited reactivity with 
lipids. However, O2- can be dismutated to H2O2. H2O2 may further form hydroxyl 
radicals (OH-·) which is far more reactive and lethally destructive than O2-. 
Mitochondria contain superoxide dismutase and glutathione peroxidase (GSH) to 
cope with free oxygen radicals by converting them to H2O. 
 
            (3) Ubiquinol:cytochrome c oxidoreductase (Complex III) 
 
Complex III is also often referred to bc1 complex (Berry et al., 2000 and Crofts 
2004). The total reaction of Complex III can be described as: 
 
QH2 + 2 cyt c3++  2H+i<==> Q + 2 cyt c 2+ + 4H+o
 
           In this reaction, complex III transfers the electrons from ubiquinol (QH2) to 
cytochrome c (Cyt c). The oxidation of every QH2 produces 2 reduced 
cytochrome c and pumps 4 protons across the inner membrane from the matrix 
side to the intermembrane side. Human complex III consists of 11 subunits. Only 
cytochome b (cyt b) is encoded by mtDNA. The transfer of electron from QH2 to 
cyt c is catalyzed by three subunits: Cyt b, cyt c1 and an iron sulfur protein 
through a two step Q cycle (Trumpowe, 1990). In the first step, one QH2   passes 
its two electrons to Complex III. One electron is passed through the iron sulfur 
protein and cyt c1 to the oxidized Cyt c3+ to form reduced Cyt c2+. The other 
electron is passed through two Cyt-b centres and delivered to ubiquinone to form 
a semiquinone (QH˙). Once QH2 is oxidized, it releases its two H+ to the 
 10
intermembrane space. The same process happens again to another QH2. The 
second QH2 contributes its two electrons to produce one more Cyt c2+ and fully 
reduces QH to QH2. Again, it pumps two H+ into the intermembrane space. Thus 
the Q cycle consumes two QH2, but generates only one in return. In the whole 
process, there is a net oxidation of just one QH2 and reduction of two cyt c, and 4 
H+ ions are pumped across the inner membrane.  
              Cytochrome c is a small, water soluble protein which transfers electrons 
from Complex III to Complex IV (Mathews,1985). It contains a heme-c prosthetic 
group. The iron in the heme group can either be in the oxidized (Fe3+) or the 
reduced (Fe2+) form. This allows the iron of cyt c serves as an electron carrier for 
transfering of electrons between Complex III and Complex IV. Besides being an 
essential component of the electron transfer chain, cytochrome c is also an 
intermediary in apoptosis. Pro-apoptotic stimuli can trigger the release of cyt c 
from mitochondria into cytosol where it activates a caspases cascade. Caspases 
are cysteine proteases which cleaves both structural and functional elements of 
the cell, resulting in cell death. 
 
             (4) Cytochrome c oxidase (Complex IV)  
               The total reaction of Complex IV can be described as: 
                                4 cyt c2++ O2 + 8H+i <==> 4 cyt c3+ + 2H2O + 4H+o
                Complex IV catalyzes the oxidation of the mobile electron carrier 
cytochrome c and passes the electron to the terminal electron acceptor O2 to 
generate H2O (Calhoun et al., 1994). Four protons are pumped from the matrix to 
the intermembrane space for each reaction (Yoshikawa et al., 2006). The 
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mitochondrial Complex IV consumes over 90% of oxygen in aerobic organisms. 
Human Complex IV contains 10 nuclear-encoded subunits and 3 mitochondrial 
DNA-encoded subunits. The mitochondria-encoded subunits I and II are the 
catalytic subunits which contain two cytochromes, the a and a3 cytochromes, and 
two Cu centres (the CuA centre and CuB centre) (Tsukihara et al., 1996). The 
electron of cyt c is transferred to the CuA centre first, then moves to Cyt a and 
next to Cyt a3 which is coupled to CuB. Cyt a3 and CuB form a binuclear center 
where O2 is reduced to H2O. During this process, Complex IV pumps 1 proton 
across the inner membrane per Cyt c oxidized.  
 
 
            (5) ATP synthase (Complex V) 
 
                         The total reaction of Complex V can be described as: 
ADP + Pi + 3H+O <=> ATP + 3H+i 
 
             A proton gradient across the mitochondrial inner membrane, which is also 
called mitochondrial membrane potential (∆ψm), is generated by the first four 
complexes (Complex I –IV) in RC. This inner membrane proton gradient is then 
used for ATP production by the ATP synthase (Complex V). Mitochondrial 
Complex V is evolutionarily conserved in different species.  The human 
mitochondrial Complex V consists of 16 subunits (Rubinstein et al., 2003). Two 
subunits are encoded by mtDNA. The mitochondrial Complex V can be separated 
into two parts, F1 and F0. F1 is the soluble portion of Complex V, localized in the 
mitochondrial matrix side. It contains ATPase activity. F0 is the membrane 
embedding portion of Complex V. It acts as a proton channel. The proton 
potential across the mitochondrial inner membrane drives protons to flow back to 
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the matrix side via the F0 portion of Complex V. The proton, which flows through 
F0, forces the ring of c-subunits to rotate (Noji et al., 2001). This rotation 
subsequently causes conformation changes of the catalytic nucleotide binding 
sites in F1. These conformation changes facilitate the reaction of ADP and 
phosphate to form ATP. Every 3 or 4 protons flowing through the inner 
membrane generate one ATP (Van Walraven et al., 1996 and Yoshida et al., 
2001).  Under certain conditions, Complex V can reversely pump protons across 
mitochondrial inner membrane from matrix to intermembrane space by the 
hydrolysis of ATP generated from glycolysis (Boyer, 1997 and Nelson et al., 
2000). 
            In summary, the mitochondrial respiratory chain contains 5 multi-subunit 
complexes (Complex I-V). During the course of oxidative phosphorylation, 
Complex I-IV generate a mitochondrial membrane potential (∆ψm) by pumping 
protons across the mitochondrial inner membrane from matrix side to 
intermembrane space. This ∆ψm then drives ATP synthesis by Complex V. Since 
ATP is the major energy supplier of various cellular processes, any mutation in 
mitochondrial RC subunits may cause severe disorders.   
   1.1.5. Mitochondrial dysfunction and disease 
         1.1.5.1 Pathogenesis of mitochondrial diseases
        Because of the central role of mitochondria in metabolism, any disorder of 
mitochondria will lead to a wide range of diseases. These diseases include 
classical mitochondrial diseases such as LHON, CPEO and KSS, degenerative 
diseases (Alzheimer's disease, Parkinson's disease. etc), diabetes, cancer and 
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aging (Schapira, 2006 and Pieczenik et al., 2007). Studies on patients with these 
diseases reveal that the mitochondrial genomic DNA and reactive oxygen species 
generated by mitochondrial OXPHOS are key players in these diseases. 
   (1) Mitochondrial disorders and mitochondrial genetics 
 Mitochondria are believed to arise from a bacterial ancestor about 1.5 
billion years ago (Wallace, 2005). Modern mitochondria still remain a double 
membrane structure as well as containing a double strand circular genome with 
mitochondrial specific replication, transcription and translation systems. During 
the course of evolution, the mitochondrial genome has continuously decreased 
in size by reducing “nonsense genes” and transfer of many essential genes to the 
nucleus genome. These two processes are helpful to distribute the essential 
genes equally into daughter cells and to increase the replication rate of these 
genes (Wallace 1982 and Andersson et al., 1998). 
 The human mitochondrial genome is a 16,569-bp circular double-stranded 
DNA which encodes 2 ribosomal RNAs (rRNA), 22 mitochondrial transfer 
RNAs (tRNA) (Chan, 2006) and 13 mitochondrial proteins (Anderson et al., 
1981). All the 13 proteins are subunits of five RC complexes (7 proteins in 
Complex I). All of the mitochondrial DNA in cells is maternally inherited from 
the oocyte’s cytoplasm (Giles et al., 1980).  
 The mitochondrial DNA has a very high mutation rate (Brown 1979). It is 
mainly because mitochondria lack an efficient DNA repair machinery and are 
highly exposed to free oxygen radicals. However, due to the large population of 
mitochondria in each cell and multiple copies (2-10) of mtDNA in each 
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mitochondrion (Wiesner et al., 1992),  mtDNA mutations usually do not affect 
all of the mitochondria in the cells. When a mtDNA mutation arises, cells 
initially contain a mixture of wild-type and mutants mtDNAs (heteropasmy). 
During the division of a heteropasmic cell, the wild-type and mutants mtDNAs 
are randomly distributed into the daughter cells. After many generations, the 
daughter cells can be segregated into two major cellular lineages, predominantly 
wild-type mtDNA or mutant mtDNA lineage. As the percentage of mutant 
mtDNA increases, the capacity for energy production of mitochondria 
decreases. Once the ratio of mutant versus wild-type mitochondria reaches a 
threshold levels, the phenotypic symptoms of mitochondrial diseases appear and 
become progressively worse (Shoffner et al., 1995). 
            (2) Mitochondrial disorders and reactive oxygen species (ROS) 
ROS includes oxygen ions, free radicals and peroxides, which are very 
small molecules and are highly reactive due to the presence of unpaired valence 
shell electrons.  OXPHOS is the major source of ROS in cells (Inoue et al., 
2003 and Turrens, 2003). When the mitochondrial respiratory chain is inhibited, 
the electrons accumulate in the early stages of RC (Complex I and Q). These 
electrons can be donated directly to oxygen to form the superoxide anion (O2.-). 
Superoxide anion can be detoxified by the mitochondrial Mn superoxide 
dismutase (MnSOD) to form hydrogen peroxide (H2O2) The hydrogen peroxide 
is converted to H2O by glutathione peroxidase (GPx). Sometimes, H2O2 can also 
be converted into the highly reactive hydroxyl radical (OH˙) by the Fenton 
reaction (Levi et al., 2001 and Craig et al., 2002). During times of 
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environmental stress ROS levels can increase dramatically, and can result in a 
situation known as oxidative stress. Chronic exposure to ROS can result in 
oxidative damage to mitochondrial and cellular proteins, lipids, and nucleic 
acids. Acute exposure to ROS can abolish the energy production of 
mitochondria by inactivation of the iron-sulfur clusters in Complex I, II, III, and 
aconitase in the TCA cycle. Recent studies have shown that the generation of 
mitochondrial ROS can affect diverse pathways such as the cell cycle (Sauer et 
al., 2001), cell proliferation (Kim et al., 2001), apoptosis (Lin et al., 2003), 
oxygen sensing (Chandel et al., 2000), metalloproteinase function (Ranganathan 
et al., 2001), protein kinases (Ramachandran et al., 2002), phosphatases 
(Pomytkin et al., 2002), and transcription factors (Hongpaisan et al., 2003). 
In addition to these two key players, mitochondria-mediated apoptosis is 
also very important during the development of mitochondrial diseases. 
Mitochondria contain a number of cell death-promoting factors, such as Cyt c 
and apoptosis-inducing factor (AIF). In some situations, such as high exposure 
to ROS, results in loss of energy production capacity, the mitochondrial 
permeability transition pore (mtPTP) will open (Petit et al., 1996: Green et al., 
1998 and Zoratti et al., 1995). Subsequently, the mitochondrial membrane 
potential will collapse and the inner membrane will swell. All of these will 
finally lead to the release of cell death-promoting factors into the cytosol. The 
release of cytochrome c will activate the cytosolic caspase cascade, which will 
finally destroy the cellular structures.  The release of AIF from mitochondria to 
the nucleus results in chromatin destruction (Liu et al., 1996).  
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             1.1.5.2 Diagnosis of mitochondrial diseases 
          The tissues most affected by mitochondrial diseases are those which have 
a high respiratory requirement, especially muscle or nerve tissue. Since 
respiration is impaired, these defects are usually accompanied by an increased 
concentration of lactate in the blood and this increase is a useful marker in 
diagnosis. If the defect is in one of the membrane electron transfer components, 
electron microscopy of biopsy samples may show abnormal mitochondrial 
morphology, rogged red fibers etc. The cristae of the inner mitochondrial 
membrane sometimes form honeycomb structures or the mitochondria may be 
vacuolated with few cristae. More specific identification of the defect can be 
achieved by assays for mitochondrial enzymes, such as cytochrome oxidase, 
ATP synthase or pyruvate dehydrogenase or by tests for the presence or 
absences of particular proteins. Sequencing mtDNA may identify the site of a 
genetic defect. 
                1.1.5.2 Mitochondrial diseases and complex I deficiency 
           Among all of the mitochondrial respiratory chain disorders, mitochondrial 
Complex I deficiency is the most common disorder. (Robinson, 1998; Smeitink 
et al., 2001 and Nijtmans et al., 2004). Mitochndrial Complex I deficiencies can 
be grouped into 3 major types based on the severity of the symptoms.  The first 
group is Leigh’s syndrome (Leigh 1951), with cardiomyopathy occurring in 
more than 40% of Leigh’s syndrome patients (Morris et al., 1996; and Rahman 
et al., 1996). This is the most common Complex I disorder (Leigh 1951). The 
second group is fatal neonatal lactic acidosis which is relatively uncommon.  
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The third group comprises patients who have hepatopathy and tubulopathy with 
very mild symptoms, such as exercise intolerance. Medically, Complex I is also 
important in a lot of aging related diseases. For example, the mitochondrial 
complex I has reduced activity in Parkinson’s disease. Moreover, the 
mitochondrial complex I is a major source of reactive oxygen species in cells, 
one of   the   major causes of aging (Turrens, 1997; St-Pierre et al., 2002 and Li 
et al., 2003). Therefore the study of complex I is an exciting and fast developing 
field of research nowadays. 
 
1.2 Mitochondrial Complex I  
1.2.1 The subunits of mitochondrial Complex I 
            The basic core of mitochondrial Complex I (bacterial NDH-1) consists of 14 
polypeptide subunits which form several important modules for electron transfer and 
proton transport. During evolution, a number of supernumerary subunits have been added 
to this basic complex. Now, Complex I comprises 37-40 subunits in aerobic fungi 
(Videira et al., 2001) and at least 45 in mammals. Human mitochondrial Complex I is 
composed of at least 45 subunits with a molecular mass of about 1,000 kDa (Lenaz, 
2006). Seven of these subunits, ND1-ND6 and ND4L, are encoded by mtDNA. They are 
hydrophobic in nature. The other 38 subunits are encoded by nDNA. The property of the 
nuclear-encoded subunits of bovine mitochondrial Complex I are listed in Table 1.1.   
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 Table 1.1 The nucleus encoded mitochondrial Complex I subunits from 
bovine heart mitochondria (Hirst et al., 2003). 
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  1.2.2 The structure of mitochondrial Complex I 
        
 
    Figure 1.4. The structure of bovine mitochondrial Complex I (Ugalde et al., 2004). 
             The low-resolution structure of mitochondrial Complex I, as determined by 
electron microscopy, can be described by L shaped, with the long arm embedded into the 
inner membrane and a short arm (peripheral arm) protruding into the mitochondrial 
matrix (Baranova et al., 2007 and Friedrich et al., 2004). It is believed that the 
mammalian, plant and the Neurospora mitochondrial Complex I have a similar structure 
(Grigorieff, 1999). 
            Bovine mitochondrial Complex I can be disrupted by  the chaotropic anion 
(perchlorate) into three fractions: flavoprotein (FP), iron-sulfur protein (IP) and 
hydrophobic protein (HP) fractions (Galani et al., 1978 and Galani et al., 1979). The FP 
fraction retains the ability to transfer electron from NADH to the electron acceptor, 
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ferricyanide. The IP and HP fractions have no obvious enzyme activity. The water 
soluble fraction (FP) contains three subunits: 51, 24 and 10 kDa subunits. The 51 kDa 
subunits (also called NDUFV1) contains the binding site for NADH and the primary 
electron acceptor, FMN. It also binds to a tetranuclear iron-sulfur center. The 24 kDa 
subunit contains a binuclear iron-sulfur center. The function of the10 kDa subunit is 
unknown. The FP fraction provides the entry point for the electron from NADH into the 
electron transport chain. 
            Bovine mitochondrial Complex I can also be separated by laury-dimethyfamine 
oxide (LDAO) into two major subcomplexes (subcomplex 1α and 1β) (Sazanov et al., 
2000 and Carroll et al., 2002). Subcomplex 1α retains the ability to transfer the electron 
from NADH to coenzyme Q1. However, subcomplex 1β, which is the membrane arm of 
Complex I, has no known function. Subcomplex 1α contains about 23 subunits, most of 
which are hydrophilic proteins. It appears that these subunits form a substantial part of 
the electron transfer pathway of Complex I. By modifying the methods for separating 
Complex I subcomplexes, subcomplex 1α can be further separated into two smaller 
subcomplex 1λ and 1γ. The 1λ subcomplex contains the basic electron transfer activity of 
complex I.  
 
1.2.3. The import of Complex I subunit  
         Human mitochondrial Complex I consists of at least 45 subunits. All of the 
subunits, except 7 mtDNA-encoded subunits, are encoded by the nuclear DNA. These 
nuclear DNA encoded subunits are synthesized in the cytosol. To fulfill their functions, 
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they need to be imported into the mitochondrial inner membrane and assembled into 
functional Complex I. 
           As described previously, mitochondria are double membrane-enclosed cellular 
organelles. The outer membrane is only permeable to the proteins smaller than 10 kDa, 
whereas the inner membrane is only freely permeable to the small molecules, such as 
oxygen, CO2 and water. This highly impermeable characteristic of mitochondria requires 
protein import machineries to facilitate the transportation of proteins from the site of 
synthesis in the cytosol into the mitochondria (Alberts et al., 1994).  
                                                                                         
 
Figure 1.5. The translocation complexes of mitochondria (Truscott et al., 2003). 
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         The transport machineries is known as translocator outer membrane (TOM) 
complex on the mitochondrial outer membrane and translocator inner membrane (TIM) 
complex on the mitochondrial inner membrane. There are two types of TIM complexes: 
TIM23 and TIM22 complexes.  Each of the TIM complexes facilitates the transportation 
of different subsets of proteins, which contain different types of mitochondrial import 
signals. Generally, proteins transported into the mitochondrial inner membrane need 
mitochondrial import signal (Mukhopadhyay et al., 2007). Two types of mitochondrial 
import signals have been described to mediate the import process: presequence and 
internal signals (Truscott et al. 2003). The presequences of mitochondrial Complex I 
subunits are listed in table 1.2.  Mitochondrial proteins with the presequence are imported 
via TIM23 complexes, whereas mitochondrial proteins with the internal signal are 
imported by TIM22 complexes. In this process, presequences direct mitochondrial 
precursor proteins via the TOM complex to the TIM23 translocase, where they are sorted 
to the matrix, inner membrane or intermembrane space (Figure 1.5). The presequences 
(10-80 amino acids in length) usually have a high content of basic, hydrophobic and 
hydrooxylated amino acids without a consensus amino acid sequence (Von Heijne et al., 
(1989). These presequences usually form an amphipathic α helix with one positive and 
one hydrophobic face which is important for receptor recognition (Schatz et al., 1996 and 
Neupert, 1997). Once the precursor proteins are delivered to the right mitochondrial 
location, the presequences are usually cleaved by the mitochondrial processing peptidase, 
since they are not necessary for the protein function The mitochondrial internal signals 
usually direct the proteins to the inner membrane, intermembrane space or outer 
membrane, depending on the property of the signal. Most of the mitochondrial internal 
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signals are harbored in the important domains of mature proteins, which are usually 
important for protein function or structure. Unlike the presequence, which is always 
localized at the N terminal of the protein, the internal signal has no specific location in 
proteins (Brix et al., 1999).  
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Talbe 1.2. The presequences or modification of mitochondrial Complex I subunits 
(Hirst et al., 2003).  
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 During the course of transportation, most of the mitochondrial proteins must be 
uncoiled or stretched out to go through the import machineries.  This process requires 
ATP binding and is monitored and stabilized by chaperone proteins, including hsp70.   
         Among 38 nuclear-encoded Complex I subunits, 18 subunits contain N-terminal 
mitochondrial import presequence, whereas, the rest contain the mitochondrial internal 
import signals.  These subunits are directed to the mitochondrial inner membrane via 
TOM-TIM import machineries. After import, these subunits are further assembled into a 
functional Complex I. 
      
1.2.4. The assembly of mitochondrial Complex I 
           Biogenesis of human mitochondrial Complex I requires the coordinated assembly 
of at least 45 subunits encoded by both the mitochondrial and nuclear genome. The 
presence of Complex I subcomplexes in Complex I deficient cells suggests that 
mitochondrial Complex I is assembled in distinct steps (Ugalde et al., 2003: Antonicka et 
al., 2003 and Scacco et al., 2003). 
             Mitochondrial Complex I assembly process is poorly understood. Structural and 
phylogenetic data suggest that some important mitochondrial Complex I subunits  co-
evolved and are assembled in distinct structures, termed modules (Finel 1998， Friedrich 
et al., 2000 and Hedderich 2004). The ‘minimal’ Complex I structure is derived from the 
combination of these modules. A typical example is E. coli Complex I: NDH-1 which 
consists of 14 intrinsic subunits. These proposed modules are the dehydrogenase module 
composed of NDUFV1, NDUFV2 and NDUFS1 subunits (homologues of the nuoF, E 
and G subunits of bacterial NDH-1), the hydrogenase module composed of NDUFS2, 
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NDUFS3, NDUFS7, NDUFS8, ND1 and ND5 subunits (homologues of the nuoD, C, B, 
I, H and L subunits of NDH-1) and the proton translocation module composed of ND2, 
ND3, ND4, ND4L and ND6 subunits (homologues of the nuo N, A, M, K and J subunits 
of NDH-1) ( Friedrich et al.,1997).  
            Studies of mitochondrial Complex I assembly in bacteria demonstrate that the 
membrane arm subunits are assembled in a different manner than the peripheral arm 
subunits. The Complex I assembly intermediates were identified by their appearance after 
the release of doxycycline inhibition of mitochondrial translation, which resumes the 
synthesis of the mtDNA-encoded ND subunits. 
            Detailed gene knockout studies in the fungus Neurospora crassa (N. crassa) also 
provide some useful informations about mitochondrial Complex I assembly. The results 
demonstrated that the membrane and peripheral arms of Complex I are assembled 
independently and that the membrane arm is derived from a small and large assembly 
intermediate. Nuclear-encoded mitochondrial Complex I subunit genes were disrupted in 
N. crassa by gene knockout and  the mutants were named nuo 9.6 to nuo 51 according to 
the molecular weight (in kDa).  
           In nuo51, the gene of the peripheral subunit containing the NADH catalytic site, 
FMN and one tetranulear iron-sulfur center is disrupted (Fecke et al., 1994). This mutant 
assembles an almost complete Complex I which lacks only the 51 kDa subunit, the 
primary structure of its FMN and FeS cluster. This is in agreement with the suggestion 
that the 51 kDa subunit, provides the binding sites for NADH, the FMN, and a 
tetranuclear FeS cluster (Weiss et al., 1991 and Walker et al., 1992). EPR signal arising 
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from cluster N-1 are modified, suggesting that the subunit harboring this cluster N-1 
changes its position in Complex I. 
             The 49 kDa subunit is one of the intrinsic peripheral subunits which is also 
present in bacterial NDH-1. In the mutant nuo49, the mitochondrial Complex I peripheral 
arm cannot be assembled, whereas the assembly of the membrane arm is not affected. 
Only one iron-sulfur cluster, N-2 can be found in this nuo49 mutant. 
             The 40 kDa subunit is one of the peripheral accessory subunits, which is not 
present in bacterial NDH-1. This subunit is homologous to a plant dihydroflavoriol 4-
reductase as well as a mammalian steroid dehydrogenase (Fearnley et al., 1992). In this 
nuo40 mutant, NADH/ubiquinone dehydrogenase activity is maintained, however, its 
Complex I is insensitive to piericidin A digestion. 
            Nuo21 and nuo20.9 are mutants in which two accessory subunits of the 
mitochondrial Complex I membrane arm are disrupted. The assembly of the peripheral 
arm with all of its redox groups is unaffected but assembly of the membrane arm is 
abolished. In the nuo21mutant, a large and a small assembly intermediate are found. The 
large assembly intermediate contains five mitochondria encoded subunits and six nuclear 
encoded subunits. Notably, a 80 kDa Complex I intermediate-associated (CIA) protein 
was identified in this large intermediate. Pulse-chase labeling with radioactive amino 
acids results showed that this 80 kDa CIA protein was constitutively labeled, whereas 
other mitochondrial Complex I subunits were transiently labeled. This suggests that 80 
kDa CIA protein is very stable and continuously recycled during the process of Complex 
I assembly. In the nuo 20.9 mutant, only the latter accumlates are found. This latter 
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accumulate only consists of two mitochondria-encoded subunits and five nuclear-
encoded subunits. 
            The most pronounced disturbance of Complex I assembly is found in the nuo9.6 
mutant. This 9.6 kDa subunit is just an accessory subunit of Complex I peripheral arm, 
which shows homology with prokaroytic type acyl-carrier protein (ACP). In the mutant 
of nuo9.6, neither the FeS cluster nor any subunit of the peripheral arm is detectable. 
Subunits of the membrane arm are also poorly assembled. However, other respiratory 
complexes are assembled normally. This suggests that acyl-carrier protein plays a very 
important role in the mitochondrial Complex I assembly. 
           Pulse-chase labelling experiments also show that in wild type N. crassa, the 
preassembled membrane arm and the large assembly intermediate of the membrane arm 
are also present but at low steady-state concentration and only accumulate transiently 
(Tuschen et al., 1990). 
           Unfortunately, the gene knockout method can be only applied for the nuclear 
encoded subunits. The seven mitochondria encoded subunits could not be disrupted in N. 
crassa. The alternative way is to knockout these seven mitochondrial genes in E. coli or 
P. Denittrificans, both of which contain the homologs of mitochondrial Complex I genes 
in their genome (Xu et al., 1993).  
            The mammalian mitochondrial Complex I assembly process might be more 
complicated, due to the presence of additional subunits in mammalian Complex I. So far, 
two models have been described for the Complex I assembly process in human 
mitochondria (Figure 1.6). One is established by analyzing the subcomplex composition 
in complex I deficient patient cells, and the other is based on the appearance of 
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subcomplexes in an inducible Complex I assembly system (Antonicka et al., 2003 and 
Ugalde et al., 2004). Although these two models differ slightly, both conclude that the 
assembly of complex I is through a combination of preassembled intermediates rather 
than through a sequential addition of different subunits.         







Human mitochondrial Complex I assembly model proposed by Antonicka, H. 
(Antonicka et. al., 2003) 
 
Human mitochondrial Complex I assembly model proposed by Ugalde, C. (Ugalde et 
al.,  2004) 
Figure 1.6. The  Human Complex I assembly models              
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1.3 GRIM-19 
            GRIM-19 (Genes associated with Retinoid-IFN-induced Mortality-19) is a small 
protein containing 144 amino acids with a molecular weight about 16 kDa.  No conserved 
motifs/domains are identified in GRIM-19. It is expressed in a wide variety of human 
tissues. Furthermore, mitochondria-rich tissues, such as human heart, skeletal muscle, 
liver, kidney, and placenta, contain much more abundant GRIM-19 than other tissues 
such as lung, peripheral blood leukocytes, spleen, thymus, and colon. The human GRIM-
19 gene is located on chromosome 19 and contains 5 exons. 
           GRIM-19 was originally identified as a nuclear protein with an important role in 
interferon-β (IFN-β) and retinoic acid (RA)-induced cell death (Angell et al., 2000). It 
was found that the combination of IFN-β and RA induced strong apoptosis in tumor cells. 
To further understand the mechanism of IFN-β and RA induced apoptosis, anti-sense 
knockout technique was employed to screen for potential regulators. Several cell death 
associated genes were identified including GRIM-19. Knockout of GRIM-19 by 
expression of GRIM-19 antisense mRNA conferred tumor cells with a strong resistance 
against IFN/RA-induced cell death. Overexpression of GRIM-19 in tumor cells enhanced 
cell death in response to IFN/RA. GRIM-19 mRNA levels were found to be up-regulated 
about 4 to 5 folds after treatment with IFN/RA. In this report,  the majority of GRIM-19 
was claimed to localize in the nucleus by immunoflurescent staining. 
            Subsequently, GRIM19 was found to associate with bovine mitochondrial 
Complex I (Fearnley et al., 2001). Bovine mitochondrial Complex I consists of at least 42 
subunits. Seven subunits are encoded by mitochondrial DNA, the other 35 subunits are 
encoded by nuclear DNA and imported into mitochondria. By separating different 
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subunits of bovine mitochondrial Complex I 1λ subcomplex in a denaturing gel, a novel 
band was identified. This band was subjected to mass-spectrometric assay, and turned out 
to be the bovine homolog of human GRIM-19. Analysis of  the intact bovine GRIM-19 
molecular weight indicated that the N-terminus of GRIM-19 was acetylated. Thus, it was 
suggested that GRIM-19 might be one subunit of bovine mitochondrial Complex I. 
           In 2003, GRIM-19 was reported to be a suppressor of STAT3 via functional 
interaction ( Lufei et al 2003: and Zhang et al., 2003). STAT3 (Signal Transducer and 
Activator of Transcription) is a latent cytoplasmic transcription factor, which can be 
activated by various cytokines and growth factors. Activated STAT3 translocates from 
the cytoplasm to nucleus and regulates the transcription of different genes. STAT3 plays 
important roles in cell proliferation and transformation, and is constitutively activated in 
various cancer cell lines. In order to further understand the regulation of STAT3, the 
yeast two hybrid method was used to screen the potential regulators. GRIM-19 was 
shown to interact with STAT3. Furthermore, this interaction was found to be specific to 
STAT3 but not STAT1 and STAT5. GRIM-19 represses the transcriptional activity of 
STAT3 partially by inhibition of the nuclear translocation of activated STAT3 by 
sequestering STAT3 to the peri-nuclear region, and attenuated. Consistently, GRIM-19 
also suppressed the cell growth of src-transformed cells (Lufei et al., 2003)      
 
1.1 Objective and significance of this study 
             In 2003, GRIM-19 was quite a novel protein. There were very few reports on 
GRIM-19. Little was known about its structure, regulation and functions. Therefore it 
was necessary to clarify several important questions. 
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(1) What is the exact subcellular localization of GRIM-19 protein? 
           Initially, GRIM-19 was identified as a nuclear protein. However, GRIM-19 
was also reported as a mitochondrial protein associating with mitochondrial 
Complex I. Thus questions were raised as to the exact subcellular localization of 
GRIM-19. Is GRIM-19 a nuclear protein or a mitochondrial protein or both? 
(2) Is GRIM-19 a subunit of mitochondrial complex I? 
          Although GRIM-19 was co-purified with mitochondrial Complex I, this did 
not mean that GRIM-19 was one subunit of mitochondrial Complex I. Several 
questions need to be further elaborated. For instance, is GRIM-19 assembled into 
mitochondrial Complex I and does GRIM-19 affect the Complex I enzymatic 
activity?  
(3) How does GRIM-19 affect the mitochondrial Complex I? 
           Further identification of GRIM-19 functional domains will help answer this 
question. Like most of mitochondrial Complex I subunits, GRIM-19 may contain 
the mitochondrial import signal and the mutation of GRIM-19 may affect the 
assembly of mitochondrial Complex I. If GRIM-19 is an enzymatic subunit in 
complex I , it may contain specific activity domains. 
            In this study, we showed that the elimination of GRIM-19 destroyed the assembly 
and electron transfer activity of Complex I and also influenced the other RC complexes in 
GRIM-19 knockout mice (Huang et al, 2004). GRIM-19 also interacts with various 
subunits of Complex I 1α subcomplex (shown in Chapter 3). These data provide strong 
support that GRIM-19 is one subunit of mitochondrial Complex I. Three major functional 
domains of GRIM-19 were further identified (shown in Chapter 4). The mitochondrial 
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import signals were defined at the N-terminus, and the electron transfer activity domain 
was found in the middle. The last 10 residues affects GRIM-19’s ability to be assembled 
into Complex I. These data provided further support that GRIM-19 is an enzymatic 
subunit of mitochondrial Complex I. We also generated a dominant negative GRIM-19, 
which can strongly decrease the mitochondrial membrane potential. This dominant 
negative GRIM-19 can serve as a useful tool to study ∆ψm, due to its low toxicity and 



































2.1 Chemicals and reagents  
            TMRE, MitoTracker Red CMXRos, TOPRO-3, ionomycin and antibodies against 
NFUFA9, NDUFS3, complex II 70kDa subunit were purchased from Molecular Probes 
(Eugene, OR, USA). VDAC antibody was purchased from Calbiochem (San Diego, CA, 
USA). HA antibody was purchased from Santa Cruz (CA, USA). TNF-α, IFN-β/RA, 
rotenone and etoposide were from Sigma (St Louis, MO, USA). Cytochrome c antibody 
was from Pharmingen (San Diego, CA, USA). GRIM-19 antibody was generated as 
described (Lufei et al., 2003) 
 
2.2 Cells culture 
            MCF-7 cells and HEK 293T cells were maintained in RPMI-1640 medium 
(Sigma, St. Louis, IL, USA) supplemented with 10% fetal bovine serum (FBS). HeLa 
cells were maintained in Eagle’s minimum essential medium (MEM) (Sigma, St Louis, 
IL, USA) supplemented with 10% (v/v) FBS.  
 
 2.3 Generation and culture of ρ0 cells 
           ρ0 cells were generated as described (Appleby et al., 1999). Briefly, human 143B 
osteosarcoma cells’ mtDNA was depleted by continuously culturing cells in Dulbeco’s 
modified Eagle’s medium (DMEM) with ethidium bromide (100 μg/ml) and 10% (v/v) 
FBS. The generated ρ0 cells were confirmed by absence of COX I and COX III by 
Western blot analysis. ρ0 cells were maintained in DMEM medium supplemented with 
uridine and pyruvate. 
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2.4 Plasmid constructions 
(1) GRIM-19 plasmids  
     The human GRIM-19 sequence was amplified by RT-PCR from HeLa cells. The 
WT GRIM-19 with complete open reading frame was cloned into the Hind III and 
Xho I sites of mammalian expression vector pXJ-40-HA. The internal and truncation 
mutants of GRIM-19 were generated using overlapping extension PCR and cloned 
into pXJ-40-HA similar to that of WT GRIM-19. Point mutations were introduced in 
GRIM-19-containing plasmids by the QuikChange™ Site-Directed Mutagenesis Kit 
(Stratagene, CA, USA), using a set of primers encompassing the inserted point 
mutations, to generate GRIM-19 G139R, G139V and GRIM-19 Y143A, Y143D, in 
which Gly139 or Tyr143 was substituted by Arg, Val, Ala, and Asp, respectively. The 
method is described in 2.7. The HA tag is at the C-termini of the GRIM-19 sequences 
in all the constructs. The constructs were sequenced to verify the deletions and point 
mutations. 
(2) Mitochondrial complex I 1λ subcomplex subunits plasmids 
       Human NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS5, NDUFS6, 
NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3 and NDUFA9 sequences were 
amplified by RT-PCR from the 1st strand cDNA library of HEK 293T cells and 
cloned into pXJ-40-HA vector. The HA tag is at the C-termini in all of the constructs.  
The sense primers of these genes are listed below: 
     NDUFS1 forward primer: 5’-ccctcgagaccatgttaaggatacctgtaaga-3’ 
     NDUFS1 reverse primer : 5’-ccgccgccgccagcatatggatggttcctc-3’ 
     NDUFS2 forward primer:  5’-ccaagcttaccatggcggcgctgagggct-3’ 
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     NDUFS2 reverse primer:   5’-ccgccgccgccaccgatctacttctccaaa-3’ 
    NDUFS3 forward primer: 5’-ccctcgagaccatggcggcggcggcggtagcc-3’ 
    NDUFS3 reverse primer:   5’-ccgcggccgccacttggcatcaggcttctt-3’ 
    NDUFS4 forward primer:  5’-ccaagcttaccatggcggcggtctcaatg-3’ 
    NDUFS4 reverse primer:    5’-ccctcgagccttttgtggatactcttgt-3’ 
    NDUFS5 forward primer:   5’-ccaagcttaccatgcctttcttggacatc-3’ 
    NDUFS5 reverse primer:    5’-ccctcgagccgggccgaggctccccctt-3’ 
    NDUFS6 forward primer:   5’-ccaagcttaccatggcggcggcgatgaccttc-3’ 
    NDUFS6 reverse primer:    5’-ccctcgagccgtggtggtgctgtctgaa-3’ 
    NDUFS7 forward primer:   5’-ccaagcttaccatggcggtgctgtcagct-3’ 
    NDUFS7 reverse primer:    5’-ccctcgagcccctgcggtaccagatctg -3’ 
    NDUFS8 forward primer:   5’-ccaagcttaccatgcgctgcctgaccacg-3’  
    NDUFS8 reverse primer:    5’-ccctcgagcccctgcggtaccagatctg-3’ 
    NDUFV1 forward primer:  5’-ccaagcttaccatgctggcaacacggcgg-3’ 
    NDUFV1 reverse primer:    5’-ccgcggccgccaagaggcagcctgccgggc-3’ 
    NDUFV2 forward primer:   5’- ccctcgagaccatgttcttctccgcggcgctc-3’ 
    NDUFV2 reverse primer:    5’-ccgcggccgccaaaggcctgcttgtacaccaaa-3’ 
    NDUFV3 forward primer:  5’-atgctggcaacacggcggctgctcggc-3’ 
    NDUFV3 reverse primer:    5’-tcagtgtcgaggtgactcccggcctga-3’ 
    NDUFA9 forward primer:  5’-ccaagcttaccatggcggctgccgcacaa-3’ 
    NDUFA9 reverse primer:    5’-ccctcgagccttttgtggatactcttgt-3’ 
         The constructs were sequenced to verify the correct gene sequences.. 
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2.5 Preparation of DH5α Escherichia coli competent cells 
 
           DH5α Escherichia coli competent cells were prepared by growing an aliquot of 
the competent cells in 100 ml Luria Bertani (LB, pH 7.5) containing 1% bacto-tryptone, 
0.5% (w/v) bacto-yeast extract, and 1% (w/v) NaCl, at 37oC on shaker until the 
absorbance at 600 nm reached 0.45 - 0.55. The culture was chilled on ice for 15 min, and 
sedimented by centrifugation at 3,000 rpm at 4oC for 10 min. The pellet was resuspended 
in 1/3 volume with RF1 buffer, pH 5.8, (100 mM KCl, 50 mM MnCl2, 30 mM KOAc, 10 
mM CaCl2, 15% (w/v) glycerol, and adjusted to pH 5.8 with 0.2 M acetic acid). The cell 
suspension was placed on ice for 15 min to 2 h, followed by centrifugation at 3,000 rpm 
at 4oC for 10 min. The pellet was resuspended in 1/12.5 volume with RF2 buffer, pH 6.8, 
(10 mM MOPS, 10 mM KCl, 75 mM CaCl2.6H2O, 15% (w/v) glycerol, and adjusted to 
pH 5.8 with NaOH), and placed on ice for 15 min. The competent cells were aliquoted 
and stored at -80oC. 
 
2.6 DNA transformation 
          Transformation of plasmids into competent cells was performed using the heat 
shock method. The plasmid was incubated with 100 μl of the DH5α Escherichia coli on 
ice for 30 min. The competent cells were heat shocked at 42oC for 60 sec, and 
immediately placed on ice for 2 min. Recovery was performed by adding 900 μl of LB to 
the competent cells, and cultured on a 37oC shaker for 1 h. The bacterial culture was 
spread onto a LB agar plate containing 50 μg/ml ampicillin, and incubated at 37oC 
overnight. Single colonies were subjected to screening by mini scale preparation of DNA 
and subsequent diagnostic restriction endonuclease digestion and/or sequencing. 
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2.7 DNA transfection by Lipofectamine 2000 
 
           Cells were seeded in 6-well culture dishes approximately 24 h prior to 
transfection. A total of 3 μg plasmid DNA in a final volume of 100 μl OPTI-MEM® I 
(reduced serum media from Gibco) was added to a second solution containing 3 μl 
Lipofectamine 2000 (Gibco) and 100 μl OPTI-MEM I. The mixture was incubated at 
room temperature for 15 min to allow the DNA-liposome complexes to form. An 
additional 1.5 ml of OPTI-MEM I was gently mixed with the complexes and the mixture 
was subsequently overlayed onto the cell culture, and incubated for 4 h at 37oC. Cells 
were washed with PBS twice, replaced with complete growth medium, and incubated at 
37oC for further experiments. 
 
2.8 QuikChange™ Site-Directed Mutagenesis 
           Site-directed mutagenesis was introduced into plasmids by QuikChange™ Site-
Directed Mutagenesis Kit (Stratagene). The mutagenic oligonucleotide primers were 
designed accordingly with the desired mutation placed in the middle of the primer and ~ 
10 - 15 bases of correct sequences on both sides. Sense primers used are outlined below, 
with the substitution mutation underlined:Sample reactions were prepared in thin-wall 
PCR tubes. 1 μl of Pfu Turbo™ DNA Polymerase (2.5 U/μl) was added to 50 μl of 
deionised water containing 5 μl of 10X Reaction Buffer, 30 ng dsDNA template, 125 ng 
oligonucleotide primer #1 (sense), 125 ng oligonucleotide primer #2 (antisense), and 1 μl 
of dNTP mix. The reactions were  heated to 95oC for 30 sec, followed by 16 cycles of 
denaturation at 95oC for 30 sec, annealing at 50oC for 1 min, and extension by the 
nonstrand-displacing action of Pfu Turbo DNA Polymerase at 68oC for 16 min 30 sec (2 
min/kb of plasmid length). The reactions were cooled to 16oC at the end of the cycle, and 
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the methylated, nonmutated parental DNA template was digested with DpnI at 37oC for 1 
h. The circular, nicked, mutated dsDNA was transformed into Epicurian COLI® XL1-
Blue supercompetent cells (Stratagene, La Jolla, CA, USA) using the heat shock method, 
and the nicks in the mutated plasmid were subsequently repaired by the supercompetent 
cells. 
 
2.9 Western blot analysis 
            Western blot analysis was performed as described (Huang et al., 2007). Briefly, 
cells were lysed in RIPA buffer [50 mM Tris-HCl, pH 7.2, 150 mM NaCl, 1% (w/v) 
deoxycholic  acid, 1% (v/v) Triton X-100, 0.1% (v/v) sodium dodecyl sulphate (SDS), 
0.25 mM EDTA] with the protease inhibitor cocktail (Roche, Basel, Switzerland). The 
proteins in lysate were fractionated by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE), and transferred to polyvinylidene difluoride (PVDF) membrane. The membrane 
was blocked with PBS containing 0.1% (v/v) Tween 20 and 1 %(v/v) bovine serum 
albumin before it was incubated with the appropriate primary and secondary antibodies.  
 
2.10 Immunoprecipitation 
          Cells were lysed in RIPA buffer. The protein concentrations were estimated using 
the Bio-Rad protein assay reagent ( Bio-Rad Laboratories, Hercules, CA, USA) 
according to the manufacture’s instructions, and reading the absorbance at 595 nm 
wavelength in a spectrophotometer. For immunoprecipitation, equal amounts of total 
protein lysates (0.5 mg-10mg) were incubated with an antibody ( ~ 2 μg) overnight with 
shaking at 4oC followed by incubation with protein A-agarose (Oncogene Research 
Products, Cambridge, MA, USA) for 1 h. The immunoprecipitates were washed 5 times 
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2.11 Immunofluorescence  
           Cells were grown on the glass coverslips. After incubation with Mitotracker 
CMXRos for 30 min, cells were fixed with cell medium containing 3.7% (v/v) 
formaldehyde for 15 min at 37oC. The fixed cells were permeablized with PBS 
containing 0.2% (v/v) Triton X-100 for 15 min and blocked with FDB [5% (v/v) normal 
goat serum, 2% (v/v) FBS and 2% (v/v) bovine serum albumin in PBS] for 1 h. The 
primary antibody (anti-HA or anti-cytochrome c) were incubated with fixed cells for 1 h. 
Following this, the fixed cells were washed 3 times with PBS with 0.1% (v/v) Triton X-
100. Subsequently, FITC-conjugated anti-rabbit secondary antibody was incubated with 
fixed cells to recognize the HA epitope. CY3-conjugated anti-mouse secondary antibody 
was used to detect cytochrome c. After washing, cells were incubated with TOPRO-3 
(1:2000 dilution) for 10 min before mounting. The cells were examined by confocal 
microscopy (Radiance 2000, Bio-Rad). 
2.12 Generation of a mouse antibody against human GRIM-19  
             Human GRIM-19 was cloned and expressed in bacteria as previously described 
(Huang et al., 2004). The mice were immunized by intraperitoneal injection with 100 μg 
of bacterially produced GRIM-19 protein and boosted with 50 μg of protein at the third, 
fourth, and fifth week. The blood was then routinely collected with a 1-week interval of 
boosting. The sera after nine boostings were directly used for immunofluorescence 
without further purification. 
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2.13 In vitro transcription and translation 
           GRIM-19 and various complex I subunits were synthesized using TnT quick 
coupled transcription/translation system (Promega). 0.5 μg of plasmid DNA was 
incubated with 40 μl of TnT T7 Quick master mix and 20 μM methionine. Translation 
was carried out at 30oC for 90 min. The translation products were separated by 12% (v/v) 
SDS PAGE gel and analyzed by Western blotting. 
 
 
2.14 Measurement of ∆ψm 
 
           Cells were incubated in culture medium containing 50 nM TMRE for 30 min at 
37 C in the dark.o  After being harvested and washed in PBS, cells were resuspended in 
buffer A (20 mM Hepes-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium 
EGTA, 1 mM dithiothreitol and 250 mM sucrose) and analyzed by FACS. 
 
2.15 Mitochondrial isolation 
 
             Mitochondria were isolated as described previously (Rajapakse et al., 2001). 
Briefly, cells were harvested, washed with PBS, and resuspended in mitochondrial 
isolation buffer (MIB) containing 10 mM Tris-HCl (pH 7.4), 10 mM HEPES, 0.5 mM 
EDTA, 250 mM sucrose, 10 mg of bovine serum albumin per ml, 12%  (v/v) Percoll, and 
proteinase inhibitor cocktail (Roche). Cells in suspension underwent Dounce 
homogenization gently 10 times on ice with a loose pestle and 10 times with a tight 
pestle. A total of 3 ml of homogenate was layered onto a previously poured Percoll 
gradient [3.5 ml of 26% (v/v) Percoll on 3.5 ml of 40% (v/v) Percoll] and centrifuged at 
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30,000 × g for 10 min. The second fraction containing mitochondria was removed and 
diluted 1:4 with cold MIB and centrifuged at 14,000 × g for 5 min. The pellet containing 
mitochondria was resuspended in MIB. Mitochondria were treated with proteinase K 
(100 ng/ml) in the absence or the presence of 1% (v/v) Triton X-100 in MIB for various 
durations. The mitochondrial proteins were separated by SDS-PAGE and subjected to 
Western blot analysis. The preparation of whole-cell lysates, separation of cytoplasmic 
and nuclear proteins, and Western blot analysis were performed as previously described 
(Lufei et al., 2003). 
 
2.16 Cytochrome c release assay  
            Cells were harvested and lysed on ice for 15 min with buffer containing 50 mM 
KCl, 5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 250 mM sucrose, 0.025% (w/v) 
digitonin and 20 mM Hepes, pH 7.2 with protease inhibitor cocktail (Roche). The lysates 
were centrifuged at 13,200 rpm (16,100 g) for 30 min to remove the debris. 20 μg of 
protein were fractionated on SDS-PAGE and subjected to Western blot analysis using 
anti-cytochrome c antibody. 
 
2.17 Blue-Native PAGE and in gel activity assay 
           Blue-Native polyacrylamide gel electrophoresis (BN-PAGE) was performed in a 
mini gel format using the BioRad Mini Protean system. Mitochondria were isolated as 
described previously (Huang et al., 2004). Freshly isolated mitochondria (about 500 μg 
proteins) were resuspended in 80 μl of extraction butter [750 mM of 6-aminocarproic 
acid, 50 mM of Bis-Tris (pH 7.0) and 10% (w/v) dodecyl maltoside]. The mitochondrial 
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proteins were solublized by frequently pippeting on the ice for 30 min. After removing 
the debris by centrifuging at 10,000 rpm for 10 min, 5 μl of 5% (w/v) Serva blue G in 
500 mM caproic acid was added into the supernatant.  The supernatant was separated by 
a polyacrylamide native gradient gel ranging from 5%-18% (w/v). Following BN PAGE, 
the proteins were transferred to PVDF membrane in transfer buffer [25 mM Tris, 192 
mM glycine, 0.05% (w/v) SDS and 20% (v/v) methanol]. The membrane was blocked 
with 5% (w/v) milk in PBS for at least 4 h. The normal Western blot assay was carried 
out as described. In-gel colorimetric reaction for oxidative phosphorylation of complex I 
was performed on the BN-PAGE as described previously (ref). 
 
2.18 Complex I spectrophotometric enzyme assay  
           Mitochondria were isolated from HEK 293T cells as described in (ref). Isolated 
mitochondria were resuspended in 0.1 M Tris-HCl buffer (pH 7.0) and sonicated for 10 
sec on ice before measurement. 25 μl of mitochondria homogenates were added into 975 
μl pre-warmed (30oC) reaction buffer (0.1 M Tris-HCl pH 7.0, 0.3 mM NADH, 0.1 mM 
Coenzyme Q1, 1 mM KCN and 2 mM NaN3). The mixture was transferred to a pre-
warmed (30oC) quartz cuvette and immediately put into a spectrophotometer. The 
absorbance of the reaction mixture was measured continuously at 340 nm for 5 min.  
After 5 min, 5 μl of 0.5mM rotenone was added to the cuvette to record rotenone-
insensitive activity of the mitochondria. 
 
2.19 Apoptosis assay (sub-G1 assay) 
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             The harvested HEK 293T cells were resuspended in 200 μl of PBS and 1 ml of 
ice-cold 70% (v/v) ethanol. The suspension was kept at -20oC for at least 30 min. The cell  
pellet was then resuspended in 100 μl ribonuclease A buffer (100 μg/ml) for 5 min at 
room temperature followed by staining with 300 μl of 50 μg/ml propidium iodide for 30 
min. The staining pattern of cell DNA was analyzed by FACS. 
 
2.20 Isolation and culture of blastocysts in vitro.  
           GRIM-19 heterozygote male and female  mice were intercrossed, and embryos at 
E3.5 were collected by flushing the uteruses of plugged females with M2 medium 
(Sigma). Blastocysts were then individually transferred to ES medium in culture slides 
(BD Biosciences) and cultured for 4 to 7 days. The blastocysts were genotyped by PCR 
after photography. 
 
2.21 Preparation of RNA 
Total cytoplasmic RNA was isolated by a one-step guanidinium 
thiocyanate/phenol/chloroform method (Chomczynski et al., 1987). Briefly, RNA was 
extracted by  the addition of a denaturing solution ( called Solution D) containing 4 M 
guanidium thiocyanate, 25 mM sodium citrate, pH 7.0, 0.5% (v/v) sarcosyl, and 0.1 M β-
mercapthoethanol, followed by the sequential addition of one tenth volume of 2 M 
sodium acetate, pH 4.0, one volume of water-saturated phenol, and one fifth volume of 
chloroform-isoamyl alcohol mixture (49:1), with vigorous vortexing after the addition of 
each reagent. RNA was clarified by centrifugation at 6,000 rpm, 4 oC, for 20 min, 
precipitated with an equal volume of -20 oC isopropanol, and placed at -20 oC for 1 h to 
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overnight. Centrifugation at 8,000 rpm, 4 oC, for 20 min was performed, and the resulting 
RNA pellet was dissolved in 0.5 ml of Solution D, re-precipitated in an equal volume of 
isopropanol, left for 1 h at -80 oC, and re-sedimented at 14,000 rpm, 4 oC, for 20 min. The 
RNA pellet was washed in 0.5 ml of 75% (v/v) ethanol, vacuum-dried for approximately 























Chapter 3  













3.1  GRIM-19 Interacts With Various Subunits of Mitochondrial Complex I. 
           In order to understand the biological function of GRIM-19, we tried to 
identify the interaction proteins of GRIM-19 by co-immunoprecipitation. The 
endogenous GRIM-19 was immunoprecipitated from mouse brain lysate. The 
proteins which bound to GRIM-19 were separated on a denaturing gel, and further 
stained with Coomassie Blue. The individual bands from the gel were sliced out 
and subjected to mass spectrometery analysis. Seven proteins were identified. 
Strikingly, 5 of these proteins (NDUFS1, NDUFS2, NDUFS3, NDUFV1 and NDUFA9) 
were mitochondrial complex I subunits (shown in Figure 3.1.A). 
           To further confirm the interaction between GRIM-19 and mitochondrial complex I 
subunits, 12 mitochondrial complex subunits were cloned from the 1st strand cDNA 
library of HEK 293T cells. The interaction between GRIM-19 and individual subunit was 
tested by co-immunoprecipitation. GRIM-19 was shown to interact with all these 12 
subunits in vivo (Figure 3.2.A). Because all of these subunits are associated together to 
form complex I, the interaction between GRIM-19 and these subunits might not be a 
direct interaction. We further identified the direct interacting protein by in vitro pull 
down assay. GRIM-19 and these mitochondrial complex I subunits were in vitro 
translated using TNT in vitro translation kit. As shown in Figure 3.2.B. GRIM-19 directly 
associated with complex I subunits NDUFS3, NDUFS4, NDUFV1 and NDUFA9. 
Interestingly, GRIM-19 also interacted  directly with itself. 
           These data showed that GRIM-19 associated with various mitochondrial complex 
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Figure 3.1.  Mouse GRIM-19 associates with mitochondrial complex I subunits.(A). 
The endogenous mouse GRIM-19 was immunoprecipitated from 20 mg protein of mouse 
brain lysate, using 40 μg of rabbit polyclonal GRIM-19 antibody. The proteins binding to 
the protein A beads were separated by 15% SDS-PAGE. The gel was stained with 
Coomassie Blue. The individual bands from the gel were sliced out and subjected to 
Mass Spectrometry analysis. The identified protein names were listed beside the bands. 


































Figure 3.2. GRIM-19 is associated with various mitochondrial complex I 
subunits (A)  Myc-GRIM-19 and various HA tagged mitochondrial complex I 
subunits ( NDUFS1, NDUFS2 ,NDUFS3, NDUFS4, NDUFS5, NDUFS6, 
NDUFS7, NDUFS8, NDUFV1, NDUFV2, NDUFV3 and NDUFA9) were co-
transfected into HEK 293T cells. After transfection for 24 hours, the cells were 
harvested and lysed with RIPA buffer. The lysate was subjected to 
immunoprecipitation assay. Myc-GRIM-19 was immunoprecipitated by Myc 
polyclonal antibody and protein A beads. The various mitochondrial complex I 
subunits were detected by anti-HA monoclonal antibody. Myc-GRIM-19 was 
detected by anti-Myc monoclonal antibody. (B) Myc-GRIM-19 and various HA-
tagged micohondrial complex I subunits were in vitro translated using TNT in 
vitro translation kit. The in vitro translated protein products were incubated in 
RIPA buffer. The pull down assay was conducted as described in (A).
 
3.2  GRIM-19 Is A Component of Mitochondrial Complex I. 
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          To obtain more direct evidence showing that GRIM-19 is a component of complex 
I, we carried out a Blue Native PAGE (BN-PAGE) assay. BN-PAGE was developed as a 
method for analyzing membrane proteins and was shown to be particularly useful for 
characterizing the assembly of mitochondrial respiratory chain complexes and their 
enzymatic activities from tissues and cell lines (Zerbetto et al., 1997: Schägger et al., 
1991 and Schägger et al., 2000). Mitochondria were isolated from mouse livers, and the 
enzyme complexes were resolved in BN-PAGE. Five major bands representing the 
oxidative phosphorylation complexes I to V were observed in gel (data not shown). The 
identity of the individual complexes was verified by Western blot analyses with 
antibodies against specific subunits of each complex (Figure.3.3, left panel). Complex I, 
the largest complex, was recognized by the antibody against the 39-kDa subunit 
(NDUFA9) and 30 kDa subunit (NDUFS3) (Hirst et al., 2003). More importantly, the 
same complex was also recognized by anti-GRIM-19 antibody, whereas the other 
complexes were not (Figure 3.3, middle panel). This result indicates that GRIM-19 is 
physically present in the native form of complex I.
3.3 GRIM-19 Is Essential for Mitochondrial Complex I Assembly and 
Enzymatic Activity. 
       By gene targeting, GRIM-19 knockout mice were generated in our group. GRIM-19 
knockout mouse showed embryonic lethality at embryonic day 9.5 (Huang et al. 2004). 
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Figure 3.3. Detection of GRIM-19 in complex I by BN-PAGE. Mitochondria from 
mouse liver were isolated, and 400 μg (lanes 1, 3 and 5) and 600 μg (lanes 2, 4 and 6) of 
mitochondrial proteins were solubilized and clarified by centrifugation. Aliquots of 
supernatants containing different mitochondrial respiratory complexes were separated by 
BN-PAGE as described in Materials and Methods and detected by Western blot analysis. 
Complexes I to V were detected by using mouse monoclonal antibodies against specific 
subunits of each complex which include the anti-OxPhos complex I 39-kDa subunit (C-
I), anti-OxPhos complex II 70-kDa subunit (C-II), anti-OxPhos complex III FeS subunit 
(C-III), anti-OxPhos complex IV subunit I (C-IV), and anti-OxPhos complex V inhibitor 
protein (C-V). GRIM-19 was detected in complex I with anti-GRIM-19 antibody (lanes 3 
and 4). Another complex I subunit NDUFS3 was detected by anti-NDUFS3 antibody.The 







cellular distribution were observed in GRIM-19 -/- blastocysts (Huang et al. 2004).  We 
subsequently determined whether GRIM-19 is essential for the complex I function using  
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GRIM-19 -/- blastocysts  Blastocysts were isolated from intercrossed mice and grown in 
vitro for 7 days. Twenty seven blastocysts with normal outgrowth and ICM size (GRIM-
19+/+ and GRIM-19+/–) and twenty seven blastocysts with retarded outgrowth of ICM 
(GRIM-19–/–) were combined. Proteins were extracted from these blastocysts and 
analyzed in two BN-PAGE assays in parallel, one for measuring the assembly of the 
complexes by Western blot analysis and another for enzymatic activity by an in-gel 
activity assay. As expected, GRIM-19 protein was detected in complex I of the wild-type 
blastocysts but was absent in the GRIM-19–/– blastocysts as examined by Western blot 
analysis (Figure 3.4.A). Strikingly, complex I could not be detected by the antibody 
against the 39-kDa subunit of complex I (Figure 3.4.A) nor by two other antibodies 
against the 30- and 17-kDa subunits of complex I (data not shown) in the GRIM-19–/– 
blastocysts. In contrast, the wild-type blastocysts displayed a normal assembly of 
complex I. The assembly of complexes II and IV was also examined and shown to be at 
reduced levels in the GRIM-19–/– blastocysts (Figure 3.4.A). Furthermore, the electron 
transfer activity of complex I was examined and shown to be totally destroyed in the 
GRIM-19–/– blastocysts compared to that in the wild-type blastocysts. As a control, the 


















Figure3.4. GRIM-19 is essential for mitochondrial complex I assembly and 
enzymatic activity.(A) GRIM-19 is essential for mitochondrial complex I assembly. 
Blastocysts were isolated and cultured in vitro for 7 days. Twenty-seven blastocysts containing 
the wild type and GRIM-19+/− and 27 blastocysts of GRIM-19−/− were combined and directly 
solubilized. A total of 20 μg of solubilized proteins was used to analyze the complex assembly as 
described in Figure 3.3. (B) GRIM-19 is essential for mitochondrial complex I activity. Samples 
from blastocysts were prepared as described in Figure 3.3. Solubilized protein (20 μg) was 
separated by BN-PAGE. In-gel colorimetric reactions for oxidative phosphorylation of complex I 




























4.1 Residues 20-30 and 40-60 Are Required for Mitochondrial Localization of GRIM-
19                                       
         GRIM-19 contains 144 amino acids (aa) with no conserved motifs/domains 
identified. In order to further study its function in mitochondrial complex I, we generated 
a series of internal deletion and truncation mutants of human GRIM-19 by deleting about 
10 aa for each mutant and attaching a hemagglutinin (HA) tag to their C-termini (Figure 
4.1). First we examined the cellular localization of the mutant proteins by 
immunofluorescence assay. Staining for wild-type (WT) GRIM-19 showed specific 
mitochondrial filament or rod-like staining which was co-localized with Mito-Tracker 
Red CMXRos. Among all the internal deletion mutants, three mutants, Δ20-30, Δ40-50, 
and Δ50-60, lost the typical punctated mitochondrial staining and exhibited diffused 
staining pattern (Figure 4.2.A). These results were further verified by cellular 
fractionation. In contrast to the WT GRIM-19 and the other mutants which were detected 
only in the mitochondrial faction, Δ20-30, Δ40-50, and Δ50-60 mutants were absent in 
the mitochondrial fraction and mislocalized in the cytosol (Figure 4.2.B). We conclude 
that aa 20-30 and 40-60 of GRIM-19 harbor mitochondrial signal sequences that 
determine its mitochondrial localization. In agreement with this, all the C-terminal 
truncation mutants shown in Figure 4.2.A were localized in the mitochondria, except for 












Figure 4.1. The Schematic diagram of GRIM-19 internal deletion and C-terminal 
deletion mutants. For internal deletion mutants, about 10 aa were deleted in each mutant 
from the N-terminus to the C-terminus. Larger deletion mutants Δ96-124, and Δ96-134 




















Figure 4.2. GRIM-19 aa 20-30 and 40-60 are mitochondrial localization signals. WT 
and the internal deletion mutants of GRIM-19 were transfected into MCF-7 cells. 
Subcellular localization of GRIM-19 proteins was detected by anti-HA primary antibody 
and FITC-conjugated secondary antibody (green). Mitochondria were labeled with Mito-
Tracker Red CMXRos (red). Cells were mounted and examined with a confocal 






4.2 Residues 134-144 Affects  GRIM-19 Insertion to Complex I  
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          Knockout of GRIM-19 in mouse blastocysts leads to disruption of the RC complex 
I assembly (Huang et al., 2004). We further investigated how GRIM-19 is assembled into 
complex I. We checked the assembly ability of different GRIM-19 deletion mutants by 
comparing their amounts present in complex I. HEK 293T cells were transfected with 
equal amount of the WT- or mutant GRIM-19 and harvested 24 h later. The RC 
complexes were resolved by Blue-Native PAGE, and the protein amounts of different 
truncation mutants in complex I were measured by Western blot analysis. Our data 
showed that the assembly ability of mutants 1-134, 1-124, 1-114, and 1-96 was 
drastically decreased in comparison with WT-GRIM-19 (Figure 4.3.A). This suggested 
that the C-terminal 10 aa (134-144) could affect the GRIM-19 assembly to complex I.  In 
support of this, internal deletion mutants with intact C-terminal 10 residues such as Δ96-
134 and Δ96-124 (Figure 4.1) exhibited restored assembly abilities (Figure 4.3.B). 
Comparison of the GRIM-19 protein sequences among different species revealed two 
highly conserved aa (Tyr143 and Gly139) in this region (Figure 4.4.A). Point mutants 
Y143A, Y143D, and G139R, in which the original aa residues were substituted by 
residues with very different structures and characteristics, displayed greatly decreased 
GRIM-19 assembly ability (Figure 4.4.B). In contrast, G139V, in which Gly was 
replaced by a similar aa, Val, displayed normal assembly. Since the HA epitope is highly 
charged which could change the property of the mutant proteins, we replaced it with 
Myc-tag in the four point mutants described above. These Myc-tagged mutants behave 
similarly to their HA-tagged counterparts (Figure 4.4.C). These results further support 









Figure 4.3. Aa 134-144 of GRIM-19 affects its assembly ability to complex I. (A) and 
(B) HA-tagged GRIM-19 mutants were transfected into 293T cells.  Blue-Native PAGE 
was used to separate mitochondrial RC complexes, and subjected to Western blot 
analysis. Anti-HA antibody was used to detect transfected WT or mutant GRIM-19 
presented in complex I (top panels). GRIM-19 antibody was used to detect both 
transfected and endogenous GRIM-19 (second panels). Mitochondrial complex II was 
detected by antibody against the 70 kDa subunit of complex II, as a control (third panels). 
Expression levels of transfected GRIM-19 were monitored by SDS-PAGE and Western 












Figure 4.4. Point mutants (G139R, Y143D and Y143A) affect the assembly ability of 
GRIM-19 to complex I. (A) Sequence comparison of the last 10 aa of GRIM-19 among 
different species. Highly conserved Gly (G) and Tyr (Y) are highlighted. (B) HA tagged 
GRIM-19 point mutants (Y139A, Y139D, G143R and G143V) were transfected into 
293T cells. The experiments were performed as described in (Figure 4.3). WT and mutant 
1-96 were included as controls. (C) Myc Tagged GRIM-19 point mutants (Y139A, 
Y139D, G143R and G143V) were transfected into 293T cells. The experiments were 
performed as described in (Figure 4.3). WT are include as controls. 
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4.3 Aa 70-80 and 90-100 Are Required for Maintenance of  ΔΨm  
           In GRIM-19 knockout blastocysts, complex I almost totally lost its enzymatic 
activity due to failure of complex I holoenzyme assembly. However, this observation did 
not answer the question of whether GRIM-19 is just a structural subunit for complex I 
architecture, or an essential enzymatic subunit. To address this, we tested whether GRIM-
19 contains a domain affecting complex I electron transfer activity by assessing the 
changes of ΔΨm. GRIM-19 mutants were transfected into MCF-7 cells and co-stained 
with the Mito-Tracker Red CMXRos. Mito-Tracker Red CMXRos is a dye that 
accumulates only in the active mitochondria and is used to detect ΔΨm. Although the 
mitochondrial staining  of the mutants Δ70-80, Δ80-90 and Δ90-100 was equally strong, 
the cells transfected with mutant Δ70-80 or Δ90-100, showed much weaker or 
undetectable mitotracker staining, whereas the mutant Δ80-90 exhibited normal 
mitotracker staining. Consistent with these results, the cells transfected with the C-
terminal truncation mutants (1-90, 1-80, and 1-70) also showed less mitotracker staining 
(Figure 4.5.l.A). The percentage of depolarized cells in each group of transfected cells is 
shown in the Figure 4.5.B. 
      To confirm that the lack of mitotracker staining was due to a loss of ΔΨm, we 
quantitatively measured ΔΨm with TMRE, a positive charged fluorescence indicator of 
ΔΨm. WT GRIM-19 and GRIM-19 deletion mutants (Δ70-80 or Δ90-100) were 
transfected into MCF-7 cells. After TMRE staining, the cells were subjected to FACS 
analysis. In cells transfected with WT GRIM-19, only 3% of cells showed low ΔΨm. In 
contrast, 13.91% and 25.86% of cells transfected with Δ70-80 and Δ90-100 deletion 










Figure 4.5. Aa 70-80 and 90-100 of GRIM-19 are required for maintenance of ΔΨm. 
(A) HA-tagged GRIM-19 internal deletion mutants (Δ70-80, Δ80-90 and Δ90-100) and 
truncation mutants (1-90, 1-80 and 1-70) were transfected into MCF-7 cells. GRIM-19 
proteins were detected with anti-HA antibody and FITC-conjugated secondary antibody 
(green). Mitochondria were labeled with Mito-Tracker Red CMXRos (red). ΔΨm was 
detected by the staining of Mito-Tracker CMXRos. Cells were mounted and examined 
with a confocal microscope (upper and lower panels). (B) 100 tranfected cells from each 
group were randomly selected, and the number of the cells that lost ΔΨm was counted 
and indicated as percentage of the total cells. The numbers represent the mean of three 












Figure 4.6. Quantitatively measurement of ΔΨm in GIRM-19 mutants transfected 
cells. Vector, WT-GRIM-19, GRIM-19 internal deletion mutants (Δ70-80, Δ90-100) and 
DN-GRIM-19 were transfected into MCF-7 cells. After transfection for 24 h, cells were 
stained with 50 nM TMRE and subjected to FACS analysis. 30,000 events were counted 
for each group. As controls, untransfected cells were either treated with 10 μM of FCCP 
for 2 h (for complete depolarization) or 4 mM of rotenone for 4 h (for inhibition of 
complex I) before harvesting for FACS. The reading of TMRE staining intensity in FCCP 
treated cells was set to 0 in FACS measurement. Percentage of total cells with low ΔΨm 
is indicated. (C) and (D) Two complex I subunits, NDUFA9 in (C) and NDUFS3 in (D) 
and the mutants are illustrated on top of the figures. Close boxes at the N-termini indicate 
the mitochondrial localization signal sequences predicted using MITOPROT server. The 
numbers represent aa contained in the WT and mutant constructs. The indirect 





uncoupler of oxidative phosphorylation, induced complete disruption of mitochondrial 
membrane potential (100%), whereas rotenone, a classical complex I inhibitor, resulted in 
98% of cells lost or with low ΔΨm (Figure 4.6). This further confirmed that deletion of 
aa 70-80 or 90-100 affect mitochondrial membrane potential.  
      To find out whether other RC complex I subunits also affect ΔΨm, we cloned two 
complex I subunits, NDUFA9 and NDUFS3, and generated truncation mutants 
containing the N-terminal 1-100 aa that include their mitochondrial signal peptides 
(Walker, 1992) followed by short sequences. Although  these deletion mutants were able 
to insert into complex I (data no shown), they did not overtly affect ΔΨm (Figure 4.7A 
and 4.7.B). These data suggest that GRIM-19 might be a subunit with special functions in 





















Figure 4.7. Deletion mutants of NDUFA9 and NDUFS3 do not affect mitochondrial 
membrane potential obviously.(A) and (B) Two complex I subunits, NDUFA9 in (A) 
and NDUFS3 in (B) and the mutants are illustrated on top of the figures. Close boxes at 
the N-termini indicate the mitochondrial localization signal sequences predicted using 
MITOPROT server. The numbers represent aa contained in the WT and mutant 
constructs. The indirect immunofluorescence experiment was performed as described in 












 Dominant negative mutant of  GRIM-19 










5.1 Generation of a Dominant Negative  GRIM-19 Mutant Which Disrupts ΔΨm  
Based on our functional domain data, we generated a potent dominant-negative 
mutant (DN-GRIM-19) containing the N-terminal 1-60 aa and the C-terminal 10 aa (134-
144) as shown in Figure 5.1.A. This mutant strongly reduced ΔΨm as shown by a loss of 
mitotracker staining (Figure 5.1.B). Only 5% of cells expressing WT-GRIM-19 or 
transfected with control vector showed less mitotracker staining, in contrast, 76% of the 
cells expressing DN-GRIM-19 showed significantly less or almost non-detectable 
mitotracker staining (Figure 5.1.C). Compared with deletion mutant 1-60, which caused 
loss of ΔΨm in 52% of transfected cells, the DN-GRIM-19 had a stronger effect with 
nealy 80% cells depolarized. This could be due to the presence of the C-terminal 10 aa in 
DN-GRIM-19, which confers better assembly ability. Its effect was further verified by 
FACS analysis in which 51.73% of the total cells showed low ΔΨm (see Figure 4.6). We 
also checked whether loss of mitotracker staining was due to impaired mitochondrial 
integrity by staining the cells with antibody against COX IV, a subunit of RC complex 
IV. As shown in Figure 5.2, although the mitotracker staining was absent in DN-GRIM-
19 expressing cells, COX IV staining in the same cells was intact. This confirmed that 
loss of ΔΨm by the DN-GRIM-19 was not due to mitochondrial damage.  
5.2 DN-GRIM-19 Compromises Complex I Activity without Affecting Its Assembly 
Since ΔΨm was reduced in cells transfected with DN-GRIM-19, we further tested 
whether this was due to a decrease of mitochondrial complex I enzymatic activity. HEK 
293T cells were transfected with WT, deletion mutant 1-60, or DN-GRIM-19. Blue-







      
Figure 5.1.DN-GRIM-19 strongly reduces 
ΔΨm. (A) Schematic diagram of DN-
GRIM-19. The numbers indicate aa. (B) WT 
and DN-GRIM-19 were transfected into 
MCF-7 cells. GRIM-19 proteins were 
detected by anti-HA primary antibody and 
FITC-conjugated secondary antibody 
(green). ΔΨm was detected with Mito-
Tracker CMXRos (red). Nuclei were stained 
with TOPRO-3 (blue). The merged images 
are shown. (C) Vector, WT-GRIM-19, 
deletion mutant 1-60, and DN-GRIM-19 
were transfected into MCF-7 cells.  
Immunostaining was performed as described 
above. 300 transfected cells were randomly 
picked. The number of cells showing low 
ΔΨm was counted, and the percentage of 
such cells was calculated and presented in 
bar graphs as the mean of three experiments 
















Figure 5.2. DN-GRIM-19 reduces ΔΨm without affecting mitochondria integrity.  
Experiments were performed as described in (Figure 5.1.B), except that instead of 
TORPO-3 staining, cells were stained with anti-COX IV antibody and CY5-conjugated 














Figure 5.3. DN-GRIM-19 decreases mitochondrial complex I electron transfer 
activity. (A) WT, DN and deletion mutant 1-60 of GRIM-19 were transfected into HEK 
293T cells. After transfection for 24 h, cells were harvested. Mitochondria from cells 
were isolated. Mitochondrial proteins were solubilized and separated by Blue-Native 
PAGE. Enzymatic activity of complex I and II were measured in gel respectively as 
described in Materials and Methods. (B and C) Transfection and Blue-Native PAGE were 
performed as described in (A), followed by Western blot analysis. Anti-GRIM-19 
antibody was used to detect the total GRIM-19 proteins in mitochondrial complex I, and 
anti-complex II 70 kD subunit antibody was used to detect the complex II, shown in (B). 
Anti-HA antibody was used to detect the amount of transfected proteins (WT, DN and 1-






activity was tested directly in gel. The results showed that in the DN-GRIM-19-
transfected cells, complex I activity was much lower than that in the WT-GRIM-19-
transfected cells (Figure 5.3.A), although the total mitochondrial complex I amount was 
not decreased when monitored by Western blotting with GRIM-19 antibody (Figure 
5.3.B). The GRIM-19 deletion mutant 1-60 also showed decreased complex I activity but 
not as potent as DN-GRIM-19. This could be due to the higher amount of DN-GRIM-19 
inserted into complex I as compared to the deletion mutant 1-60 (Figure 5.3.C). 
We also quantitatively determined mitochondrial complex I enzymatic activity by 
measuring the NADH oxidation rate using spectrophotometric assay. The rate of NADH 
oxidation is proportional to the slope of the kinetic curve. As shown in Figure 5.4.A, the 
overall NADH oxidation rate in DN-GRIM-19 and GRIM-19 mutant 1-60 transfected 
cells was much slower than that in the vector or WT GRIM-19 transfected cells. 
However, after addition of rotenone, the oxidation rates of the remaining NADH were 
similar in all of the four groups. The rotenone sensitive NADH oxidation rate 
(proportional to complex I activity) was calculated by subtracting the NADH oxidation 
rate after addition of rotenone from the total NADH oxidation rate (Figure 5.4.C). The 
results showed that vector and WT GRIM-19 transfected cells recorded complex I 
activity of about 0.022 OD/sec and 0.024 OD/sec respectively, whereas GRIM-19 
deletion mutant 1-60 transfected cells had low complex I activity of about 0.012 OD/sec 
and DN-GRIM-19 transfected cells with the lowest complex I activity of 0.008 OD/sec. 
Both of them had much lower complex I activity (55% and 36%, respectively) compared 











Figure 5.4. The NADH oxidation rate is decreased in DN-GRIM-19 transfected cells. 
(A) HEK 293T cells were transfected with vector, WT, DN-GRIM-19, or GRIM-19 1-60. 
Mitochondrial fraction was isolated and NADH oxidation was measured every 20 sec as 
described in Materials and Methods. Rotenone was added at the time point of 300 sec. 
The rate of NADH oxidation of each cell populations is indicated by change of OD 
reading at wavelength 340 nm per 20 sec which is listed in Table 2. (B)The same amount 
of mitochondria was lysed and subjected to Western blot analysis. NDUFA9 antibody 
was used to monitor the amount of complex I and the expression levels of transfected 
plasmids are shown by probing with anti-HA antibody. (C) The rotenone sensitive 
complex I activity was quantified from data shown in (D) and indicated with a bar graph. 
The numbers represent the mean of three independent experiments with standard 
deviation (S.D.) given as error bars. 
 
 
Talbe 2. The NADH oxidation rates in vector , GRIM-19, DN-GRIM-19 and GRIM-19 
1-60 transfected cells. 
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ρ0 cells lack functional RC due to depletion of the mitochondrial DNA. However, 
in these cells, mitochondria are capable of regaining their ΔΨm in a RC-independent 
pathway as reported previously (Appleby et al., 1999). If DN-GRIM-19 disrupted ΔΨm 
by decreasing the complex I activity, it was predicted that this mutant would not affect 
ΔΨm in ρ0 cells. It appears to be the case as DN-GRIM-19 did not change ΔΨm in ρ0 
cells, but was able to disrupt ΔΨm in parental 143B cells (Figure 5.5). These results 
indicate that a loss of ΔΨm in cells expressing DN-GRIM-19 is correlated to the decrease 
of the complex I enzymatic activity.  
In the GRIM-19 knockout blastocysts, complex I cannot be assembled and the 
amounts of complexes II, III, IV, and V were also decreased. In agreement with these 
observations, the protein levels of some individual subunits of the RC complexes were 
also downregulated (Huang et al., 2004).  However, we did not observe a similar effect 
from DN-GRIM-19 (Figure 5.3.A and 5.3.B, for complex II assembly and activity). 
Furthermore, expression levels of various RC complex subunits remained unaffected 
(Figure 5.6). These results suggest that DN-GRIM-19 does not affect mitochondrial 
complex I assembly. Altogether, these data suggest that GRIM-19 is not only required for 
the complex I assembly, but also critical for its electron transfer activity and maintenance 
of ΔΨm. The functional domain for this activity resides in the region of aa 70-100, which 
is distinct from that responsible for the complex I assembly (aa 1-60 and 134-144).  
5.3 Loss of ΔΨm Caused by DN-GRIM-19 does not Induce Cytochrome c Release and 
Apoptosis 
Since DN-GRIM-19 specifically decreased ΔΨm, we further examined apoptosis 










Figure 5.5. DN-GRIM-19 does not reduce ΔΨm in ρ0 cells DN-GRIM-19 was 
transfected into human 143B cells or ρ0 cells. DN-GRIM-19 proteins were detected by 
anti-HA polyclonal primary antibody and FITC-conjugated secondary antibody (green). 














Figure 5.6. DN-GRIM-19 does not affect the expression of various mitochondrial 
subunits. The same samples for Blue-Native PAGE described in (Figure 5.3) were 
denatured by boiling in the equal volume of 2X protein loading buffer, separated with 
SDS-PAGE, and subjected to Western blotting with anti-complex II 70 kD subunit, anti-
NDUFA9, anti-NDUFS3, anti-VADC, anti-GRIM-19, and anti-HA antibodies. Anti-
GRIM-19 antibody was used to detect the endogenous GRIM-19, whereas anti-HA 









which had been stably transfected with caspase 3 and thus has the ability to undergo 
apoptosis upon death stimulation, was used in the following experiments. Although DN-
GRIM-19 disrupted ΔΨm, there was an absence of cytochrome c release from 
mitochondria (Figure 5.7.A). Live cells transfected with GFP-tagged DN-GRIM-19 
(Δ60-134-GFP) were monitored using time-lapse microscopy. DN-GRIM-19-GFP also 
caused ΔΨm loss in these cells as shown by the lack of mitotracker staining (Figure 
5.7.B).  Although short exposure to UV light from live cell imaging microscopy was 
detrimental to cells and resulted in abnormal cell morphology, neither untransfected nor 
DN-GRIM-19-transfected cells showed typical apoptosis. Moreover, as controls, cells 
transfected with DN-GRIM-19-GFP without exposure to UV light maintained the normal 
morphology (data not shown).  
5.4 Loss of ΔΨm Caused by DN-GRIM-19 Sensitizes Cells to Undergo Apoptosis  
Although cells transfected with DN-GRIM-19 did not undergo apoptosis under 
normal growth conditions, we tested whether these cells were sensitized to undergo cell 
death when challenged with death stimuli. Transfected cells were treated with 
staurosporine for various periods, and cytochrome c release was examined by Western 
blot analysis. There were higher amounts of cytochrome c release in the DN-GRIM-19-
expressing cells at early time points (8 and 16 h) after staurosporine treatment. However, 
in cells expressing WT-GRIM-19, cytochrome c release was delayed as shown by high 
level of cytochrome c release only after 24 h of treatment (Figure 5.8.A). The kinetic 
analysis was also carried out in the transfected cells treated with TNF-α. At 3h, 
cytochrome c release was apparent in the cells expressing DN-GRIM-19 but not WT-
GRIM-19 (Figure 5.8.B). Consistent with the Western blotting results, the 
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immunofluorescence results showed that the WT-GRIM-19-expressing cells displayed 
normal cytochrome c staining in the mitochondria, whereas the DN-GRIM-19-transfected 
cells showed diffused cytochrome c staining in the cytoplasm (Figure 5.8.C). The 
statistical data for cell death were obtained in the cells transfected with vector, WT-, or 
DN-GRIM-19 after treatment with TNF-α, rotenone, ionomycin, or IFN/RA. As shown 
in Figure 5.9.A-D, rotenone, ionomycin or TNF-α induced higher rates of cell death in 
the transfected cells than untreated cells. However, a much higher percentage of cell 
death (~2-fold) was observed in cells expressing DN-GRIM-19 than in those expressing 
WT-GRIM-19 or vector. IFN/RA treatment caused prolonged cell death through different 
mechanisms (Huang et al., 2007).  In these cells, there was no obvious difference 
between cells transfected with WT- and DN-GRIM-19 (Figure 5.9.D). Apoptosis was 
also analyzed by PI staining followed by flow cytometry. The apoptotic cells were 
characterized by sub-G1 population due to DNA fragmentation and consequent loss of 
DNA content. As shown in Figure 5.9.E, about 24% of the DN-GRIM-19 tranfected cells 
underwent apoptosis after treatment with etoposide, in comparison with 11% of the 
vector or WT transfected cells. This suggests that DN-GRIM-19 transfected cells are 








Figure 5.7. Loss of ΔΨm caused by DN-GRIM-19 does not induce cytochrome c 
release and apoptosis. (A) WT and DN-GRIM-19 were transfected into MCF-7 cells 
which stably express caspase-3. The transfected GRIM-19 were detected by anti-HA 
primary antibody and FITC-conjugated secondary antibody (green). ΔΨm was detected 
by Mito-Tracker Red CMXRos staining (red). Cytochrome c was detected with anti-
cytochrome c antibody. The merged images are shown. (B) GFP-tagged DN-GRIM-19 
(green) was transfected into MCF-7 cells stably expressing caspase 3, and cells were 
stained with Mito-Tracker Red CMXRos (red) 24 h after transfection. Nuclei were 
stained with Hoechst 33342 (blue). Cells were monitored under live cell microscopy for 3 
days and pictures were taken at day 1, 2 and 3. Scale bar = 10 μm. 
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 Figure 5.8. DN-GRIM-19 sensitizes cells to cytochrome c release. (A) WT- and DN-
GRIM-19 were transfected into HeLa cells. 24 h after transfection, cells were incubated 
with 1 μΜ of staurosporine for various times. Cytochrome c release assay was conducted 
as described in Material and Methods. (B) WT and DN-GRIM-19 were transfected into 
MCF-7 cell line stably expressing caspase 3. 24 h after transfection, cells were either 
untreated (un) or treated with 4 ng/ml TNF-α for the period as indicated. Cytochrome c 
release assay was performed as described in (A). (C) WT and DN-GRIM-19 were 
transfected into MCF-7 cells as described in (B) and cells were treated with TNF-α for 3 
h. Immunofluorescence experiments were conducted. GRIM-19 proteins were detected 
with polyclonal anti-HA antibody and Cy5-conjugated secondary antibody (blue). 
Cytochrome c was detected with anti-cytochrome c monoclonal antibody and FITC-























Figure 5.9. DN-GRIM-19 sensitizes cells to apoptosis. (A) MCF-7 cells stably 
expressing caspase 3 were transfected with vector, WT or DN-GRIM-19. 24 h after 
transfection, cells were treated with 4 ng/ml of TNF-α for 8 h. Immunofluorescence 
experiments were conducted as described in (Figure 5.6.C). 300 transfected cells were 
randomly picked. The number of cells showing cytochrome c release was counted, and 
the percentage of such cells was calculated and presented in bar graphs as the mean of 
three experiments with standard deviation (S.D.) given as error bars. (A-D) HeLa cells 
were transfected with vector, WT or DN-GRIM-19 and treated with rotenone (5 μM) for 
10 h, ionomycin (200 μM) for 24 h, or IFN-β (1000 u/ml) and RA (2 µM) for 48 h. The 
experiments were performed as described in (A). (E) HEK 293T cells were transfected 
with vector, WT, or DN-GRIM-19. Cells were either untreated or treated with etoposide 
for 24 h. DNA content was analyzed by flow cytometry after staining with PI.  The 
percentage of sub-G1 cells is indicated. The data show a representative of three 






















6.1 GRIM-19 Is Localized in Mitochondria  
         The cellular location of a protein is a key factor in determining its basic biological 
function. GRIM-19 was originally reported as a “nuclear” protein (Angell et al., 2000). 
Surprisingly, GRIM-19 was also found to associate with mitochondrial complex I 
(Fearnley et al., 2001). These controversial data have made the exact cellular localization 
of GRIM-19 elusive. Thus, whether GRIM-19 is a nuclear protein or a mitochondrial 
protein becomes a crucial issue to address. More and more evidence showed that GRIM-
19 is present in mitochondria. The mitochondrial localization of GRIM-19 was 
demonstrated by indirect immunofluorescence and cellular fractionation in various cell 
types and species (Lufei et al., 2003 and Huang et al., 2004). The research group, which 
first identified GRIM-19 as a nuclear protein, also reported later that GRIM-19 was 
localized in the perinuclear and cytoplasm region (Kalvakolanu, 2004). In this study, we 
provided the most direct evident to show GRIM-19 is present in mitochondria. Our data 
showed that GRIM-19 is physically present in mitochondrial complex I by interacting 
with various mitochondrial complex I subunits. Moreover, the exact mitochondrial 
localization signals of GRIM-19 were further identified at aa 20-30 and 40-60. By 
examining the cellular localization of more than 24 GRIM-19 deletion mutants, we found 
that all of the mutants are exclusively localized in the mitochondria except three that 
displayed diffused staining patterns, primarily in the cytoplasm (Figure 4.2 and data not 
shown). Moreover, the translocation of GRIM-19 to nucleus was not observed during 
IFN/RA treatment (Huang et al., 2007). All these data suggest that GRIM-19 is primarily 
a mitochondrial protein and its biological roles are more likely to be based on its function 
in mitochondria.      
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6.2 GRIM-19 Is a Critical Subunit of RC Complex I 
6.2.1 GRIM-19 is essential for mitochondrial complex I assembly and activity. 
GRIM-19 was previously reported to co-purify with mitochondrial complex I in 
bovine heart (Fearnley et al., 2001). However, this does not necessarily mean that GRIM-
19 is a subunit of mitochondrial complex I.  Since some proteins associating with 
mitochondrial complex I were not mitochondrial complex I subunits (Rutger et al., 2007; 
Vogel et al., 2005 and Kuffner et al., 1998), the relationship between GRIM-19 and 
complex I need to be further investigated. In this study, we showed that endogenous 
GRIM-19 associated with various subunits of mitochondrial complex I, and directly 
interacted with 4 complex I subunits NDUFV1, NDUFA9, NDUFS3 and NDUFS4. 
Moreover, GRIM-19 knockout mice completely abolished the mitochondrial complex I 
assembly and activity. All these data, together with previous report (Fearnley et al., 2001) 
indicate that GRIM-19 is a subunit of mitochondrial complex I.  
 6.2.2 GRIM-19 is a functional subunit in mitochondrial complex I. 
Although genetic evidence indicates that knockout of GRIM-19 in mouse 
blastocysts or knockdown of GRIM-19 in Xenopus embryos impairs complex I assembly 
and activity (Chen et al., 2007), these results do not reveal the mechanism of how it 
functions in complex I. In other words, it is unclear whether loss of complex I enzymatic 
activity in the GRIM-19 knockout cells was due to a failure of complex I assembly or 
activity, or both. In this study, we defined the functional domains of GRIM-19. As 
summarized in Figure 6.1, the N-terminal domain (aa 1-60) is essential for the 



















Figure  6.1. Functional domains of GRIM-19. The mitochondrial targeting sequences 
and functional domains are summarized in a schematic diagram. The numbers indicate aa 
of GRIM-19. The red, yellow, and green boxes represent sequences for mitochondrial 
targeting, maintenance of ΔΨm, and enhancing assembly, respectively. TM: predicted 







middle region (aa 70-100) is critical for the electron transfer activity. The last C-terminal 
10 aa promotes GRIM-19 assembly to complex I. In DN-GRIM-19 transfected cells, 
mitochondrial complex I assembly is not disturbed, however, mitochondrial complex I 
enzymatic activity decreases dramatically. In other word, DN-GRIM-19 decreases 
mitochondrial complex I activity without affecting complex assembly. These data clearly 
demonstrate that GRIM-19 is a functional subunit of complex I that is not only important 
for complex I assembly but also essential for its electron transfer activity. In addition, we 
showed that GRIM-19 has a unique role in the maintenance of ΔΨm. The domain for this 
function overlaps with its electron transfer activity. GRIM-19 is the first complex I 
protein that is studied in such detail. These data and the various mutants we have 
generated in this study will facilitate further investigation for the mechanisms of complex 
I assembly and function.  
6.3 The Position of GRIM-19 in Mitochondrial Complex I 
 Mammalian mitochondrial complex I contains at least 45 subunits. These 
subunits are assembled into an L shape structure, with a long arm embedded into the 
inner membrane and a short arm (peripheral arm) protruding into the mitochondrial 
matrix. The whole mitochondrial complex I can be separated into several small 
subcomplexes (1λ, 1γ and 1β subcomplexes). 1λ subcomplex represents the peripheral 
arm, 1γ subcomplex represents a small part embedded in the inner membrane, which is 
linked with 1λ subcomplex. Since we have shown that GRIM-19 is a subunit of 
mitochondrial complex I, where is GRIM-19 in mitochondrial complex I?  Our results 
indicated that GRIM-19 might be a transmembrane subunit linking mitochondrial 1λ and 
1γ subcomplexes.  Immunoprecipitation experiments showed that endogenous GRIM-19 
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associated with 5 mitochondrial complex I subunits (NDUFS1, NDUFS2, NDUFS3, 
NDUFV1 and NDUFA9). Among these 5 subunits, NDUFS1, NDUFS2, NDUFS3 and 
NDUFV1 belongs to mitochondrial 1λ subcomplex, whereas NDUFA9 is present in 1γ 
subcomplex (Figure 1.4). Previous report (Fearnley et al., 2001) showed that GRIM-19 
was present only in mitochondrial 1λ subcomplex. However, our data showed that 
GRIM-19 can also associate with a 1γ subcomplex subunit. This data suggest that GRIM-
19 might be a subunit linking 1λ and 1γ subcomplexes.  
To link the peripheral arm (1λ subcomplex) with a part of membrane embedding 
arm (1γ subcomplex), GRIM-19 must be a transmembrane protein. Interestingly, a 
potential transmembrane α-helical domain between residues 29 and 47 in GRIM-19 has 
been predicted (Fearnley et al., 2001), which overlaps with our identified mitochondrial 
targeting sequences. Consistent with this prediction, the N-terminal of GRIM-19 was 
resistant to proteinase K digestion (data not shown). Our data is helpful to further define 
the position of GRIM-19 in complex I. 
6.4 The Important Function of Accessory Subunits in Mitochondrial Complex I. 
            The basic core of mitochondrial complex I (bacterial NDH-1) consists of 14 
subunits which form several important modules for electron transfer and proton transport. 
During evolution, a number of accessory subunits have been added to this basic complex 
I. Now, mitochondrial complex I comprises 37-40 subunits in aerobic fungi and at least 
45 in mammals (Videira et al., 2001 and Lenaz, 2006). What is the function of these 
accessory subunits? Are they also important for mitochondrial complex I? 
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GRIM-19 is not one of  the 14 intrinsic subunits of mitochondrial complex I. 
However, the deletion of GRIM-19 in mice caused a very pronounced disturbance of 
complex I. The elimination of GRIM-19 destroyed the assembly and electron transfer 
activity of complex I and also influenced the other complexes in the mitochondrial RC. 
Moreover, DN-GRIM-19 decreases mitochondrial membrane potential drastically, 
whereas a deletion mutant of NDUFS3, one of the core subunits, does not cause an 
obvious affect on the mitochondrial membrane potential. All these data indicate the 
importance of GRIM-19 in mitochondrial complex I. This is unexpected since GRIM-19 
was believed to be a small accessory subunit of complex I. A similar observation was 
made to a small accessory subunit in N. crassa. As mentioned in the introduction (1.2.4), 
deletion of a 9.6 kDa accessory subunit in N. Crassa also caused the most severe defect 
in complex I.  Both indicate that the accessory subunits may also have critical effects on 
mitochondrial complex  I, besides the 14 complex I intrinsic core subunits.   
6.5 DN-GRIM-19 as a Novel Tool for Functional Study of ΔΨm in Apoptosis 
The role of ΔΨm in apoptosis has been widely studied, with contradictory results 
reported in different systems. It remains unclear whether loss of ΔΨm is an initiator or an 
effector of apoptosis, and whether it is necessary for the induction of apoptosis at all (Ly 
et al., 2003). A decrease of ΔΨm was reported in early apoptotic process in many 
systems, and cells with low ΔΨm underwent spontaneous apoptosis (Zamzami et al., 
1995; Chen, 1997). However, contrary evidence showed that disruption of ΔΨm did not 
induce rapid apoptosis, and was therefore not a prerequisite for cell death (Finucane et 
al., 1999). Other evidence suggested that loss of ΔΨm might be a late and subsequent 
event in apoptotic pathways (Ly et al., 2003). The relationship between loss of ΔΨm and 
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cytochrome c is also controversial. It has been reported that loss of ΔΨm proceeds 
cytochrome c release (Goldstern et al., 2000), and a two-step process required for 
cytochrome c release has been proposed (Ott et al., 2002) as opposed to the “all or 
nothing” release model (Martinou et al., 1996). In our study, surprisingly, we found that 
the middle region of GRIM-19 is essential for the maintenance of ΔΨm (Chapter 4). By 
the use of the DN-GRIM-19 mutant, we showed that permanent loss of ΔΨm itself is not 
sufficient to trigger the release of cytochrome c (Chapter 5). However, it sensitizes cells 
to undergo cell death when stimulated by the classical death signals (Chapter 5). Our 
results support the idea that normal ΔΨm and/or complex I activity protects against the 
initiation of apoptosis triggered by death stimuli. Therefore, this DN-GRIM-19 mutant, 
which is more specific and less toxic in comparison to ρ0 cells and the complex I 
inhibitors, provides a novel model for further studies of complex I/ΔΨm functions in 
apoptosis. 
6.6 RC/Complex I Regulates Cell Death via Different Mechanisms 
  Prolonged treatment by a combination treatment of IFN/RA causes cancer cell 
death (3-5 days) (Huang et al., 2007). Previously, we demonstrated that this treatment 
induces expression of GRIM-19, as well as other subunits of mitochondrial complex I, 
III, IV, and V. We also showed that the RC regulates IFN/RA-induced cell death by 
affecting target gene expression and ROS production. However, RC does not exert 
similar effects on cell death stimulated by the classical death reagents such as UV and 
staurosporine, which induce cell death more rapidly (Huang et al., 2007). In our current 
study, we demonstrated that the complex I activity, more specifically, an intact ΔΨm, is 
important for protecting cells from apoptosis triggered by the classical death reagents. 
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This agrees with our previous report and further reveals that, in addition to energy 
production, GRIM-19 is widely involved in protecting or promoting cell death induced 
by different death agents via distinct mechanisms.  
6.7 GRIM-19 could be a potential therapy candidate in diseases. 
Mitochondria are the “powerhouse” of the cells. The dysfunction of mitochondria 
usually cause severe diseases with multi-system disorders, including classical 
mitochondrial diseases such as Leber’s hereditary optic neurophaty (LHON), chronic 
progressive external ophthalmopelia (CPEO), Kearns-Sayre Syndrome (KSS) (Holt et al., 
1988).In the recent years, mitochondrial dysfunctions were also linked to 
neurodegenerative disorders, cancer, diabetes and aging. Most of these diseases are 
associated with accumulation of mutant mtDNAs, loss of mitochondrial RC activity and 
overproduction of ROS. For example, mitochondria function diminishes with aging, 
whereas more toxic ROS are generated. The accumulated ROS will lead to lipid 
peroxidation, the inactivation of mitochondrial RC enzymes and mutations of mtDNA. 
Among all the mitochondrial disorders, mitochondrial complex I deficiency is the 
most frequently encountered. Moreover, mitochondrial complex I is the major source of 
ROS in cells, which is the key player involved in various mitochondrial diseases. 
Therefore, the study of mitochondrial complex I function in diseases becomes a very 
exciting and fast developing field of research. 
In the past 6 years, GRIM-19, a novel subunit of mitochondrial complex I, has been 
shown to be involved widely in diseases. 
6.7.1 GRIM-19 and embryonic development disorders 
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In order to reveal the biological role of GRIM-19, GRIM-19 knockout mouse was 
generated by gene targeting (Huang et al, 2004). It was found that GRIM-19 is 
essential for embryonic development, as homologus deletion of GRIM-19 caused 
embryonic lethality at embryonic day 9.5. In addition, retarded growth and abnormal 
mitochondrial structure, morphology, and cellular distribution were observed in 
GRIM-19-/- blastocysts. Because homology deletion of GRIM-19 causes early 
embryonic lethality at embryonic day 9.5 in mice, a Xenopus laevis model with a 
partial knockdown of GRIM-19 was generated in our group. The results from 
knockdown Xenopus laevis demonstrated that GRIM-19 is necessary for early heart 
development by regulating Ca2+ homeostasis and the Ca2+-dependent NFAT signaling 
pathway (Chen et al., 2007). These studies revealed the important role of GRIM-
19/RC in embryonic development. 
6.7.2 GRIM-19 and cancer 
After GRIM-19 was identified to play important roles in IFN-β and RA-induced 
tumor cell death (Angell et al., 2000), the relationship between GRIM-19 and tumor 
was further elucidated in clinical research. The somatic and germline mutations 
(A26V, K88N, S83G, and R198P) in GRIM-19 were found in thyroid tumors 
(Maximo et al., 2005). A proteomic analysis also revealed the loss of GRIM-19 
expression in renal cancer (Alchanati et al., 2006). In addition, a cancer related 
protein GW112, which is highly expressed in a number of human tumor types, was 
also reported to promote tumor survival by associating with GRIM-19 (Zhang et al., 
2004 and Kobayashi et al., 2007). Recently, the mechanism of the GRIM-19/RC-
mediated cell death induced by IFN/RA has also been discovered in tumor cells 
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(Huang et al., 2007). It was demonstrated that IFN-β and RA upregulated the 
expression of RC subunits and RC activity. The increased RC activity subsequently 
led to overproduction of ROS, which caused the cell death in tumor cells. Most 
recently, GRIM-19 was reported to act as a tumor suppressor to inhibit cell 
transformation induced by constitutively activated Stat3 (Kalakonda et al., 2007).  
6.7.3   GRIM-19 and bacterium/virus infection  
GRIM-19 is also shown to play important roles during bacterial and viral 
infection. Nucleotide oligomerization domain 2 (NOD2), a mammalian cytosolic 
pathogen recognition molecule, was shown as an anti-bacterial factor. GRIM-19 
interacted with NOD2 and was required for NF-КB activation following NOD2-
mediated recognition of bacterial muramyl dipeptide (Barnich et al., 2005). Recently, 
GRIM-19 has aslo been reported to be involved in viral infections. A viral RNA 
product, β2.7 RNA, encoded by human cytomegalovirus interacts with GRIM-19 and 
complex I. This interaction stabilizes ΔΨm, sustains ATP production, and protects 
infected cells from rotenone-induced apoptosis (Reeves et al., 2007). In addition, 
U95, a protein product of human herpesvirus 6 (HHV-6) was shown to associate with 
GRIM-19 and caused the loss of mitochondrial membrane potential (Yeo et al., 
2007). 
       In summary, these reports show that GRIM-19 is involved in a wide variety of 
diseases.  In embryonic development, loss of GRIM-19, which represents to the whole 
mitochondrial complex I deficiency, leads to severe multi-system disorders. In tumor, 
GRIM-19 acts as pro-apoptotic protein. Point mutation or loss of GRIM-19 promotes the 
survival of tumor cells. Upregulation of GRIM-19 in tumor cells will facilitate cell death. 
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During virus infection, different viruses use different approaches to regulate GRIM-19 
function, subsequently affect mitochondrial membrane potential. These observations 
strongly suggest that GRIM-19 might be a very important regulator in diseases by 
affecting mitochondrial function or membrane potential. Since a lot of mitochondrial 
diseases, such as Alzheimer's disease, Parkinson's disease, cancer and aging, are 
accompanied with a loss of RC activity and membrane potential (Cassarino et al., 1998), 
some drugs are designed to increase the RC activity or stabilization of mitochondrial 
membrane potential (Schapira, 1999). GRIM-19 could serve as a very good candidate due 
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